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Abstract  
Objective:      A  diagnosis  of  cancer  increasingly  means  living  with  a  chronic  disease 
whereby life is preserved but the individual has adverse experiences to manage in relation 
to  treatment  and  illness  symptoms.    Accordingly,  research  has  focused  on  factors 
associated with psychological adjustment, one example being that of the expression of 
emotions.    The  purpose  of  this  review  was  to  summarise  findings  on  the  association 
between emotional expression and psychological adjustment in patients with a diagnosis of 
cancer.  Specific questions are outlined in relation to the concepts of emotional expression 
used by researchers, the expression of separate emotions and the methods used to measure 
this construct.   
Methods: Following searches of electronic databases and key journals, 15 papers reporting 
on  the  outcomes  of  13  individual  studies  met  inclusion  criteria.    Assessment  of 
methodological quality was applied using a specifically designed rating tool. 
 Results: Findings from the majority of studies indicate that attempts to suppress, inhibit or 
control  emotional  expression  is  linked  to  poorer  psychological  adjustment  and  the 
expression  of  emotions  is  associated  with  better  adjustment.    Several  studies  found 
suppression of certain emotions but not others were linked with psychological adjustment, 
however specific relationships were not consistent across studies.  Only two studies used 
methodologies other than self-report to measure emotional expression and there were some 
discrepancies in findings between these two approaches in relation to their association with 
both each other and psychological adjustment.        
Discussion:  Main  findings  are  outlined.  Methodological  strengths  and  limitations  are 
discussed with recommendations for future research and clinical practice implications.   
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Introduction 
Psychological adjustment in cancer patients 
Previously, until the 1950s, a diagnosis of cancer meant an expectation of death for the 
patient.  With the beginning of chemotherapy and improvements in life-sustaining supports 
at this time, came the first studies on psychological reactions to cancer [1].  From the 
1960s onwards there was an emphasis on palliative care and an increase in concern from 
the  field  of  psychology  about  care  for  the  terminally  ill  [1].      As  technology  further 
advances, an increasing number of people are living with what is now a chronic illness, 
whereby life is preserved but the individual has various adverse experiences to deal with in 
relation to treatment and illness symptoms.  As such, with what have recently been termed 
“survivorship initiatives”, there has been a move towards a focus on improving ongoing 
care for those living with and beyond cancer, in addition to high quality end of life care 
[2].  Accordingly, professionals caring for people with cancer and researchers in the field 
of  “psycho-oncology”  have  turned  their  focus  to  patients‟  psychological  adjustment  to 
cancer  [3].    Prevalence  rates  vary  according  to  assessments  used  but  an  early 
comprehensive study by Derogatis and colleagues found that 47% of new admissions to 
three collaborating cancer centres met criteria for a formal diagnostic psychiatric disorder 
[4].  More recent reports suggest that around 35% of patients with cancer experience a 
level of distress consistent with a psychiatric disorder [5], with 15-20% experiencing levels 
that are sub-clinical but significant enough to impact on the individual‟s health and quality 
of life [6].  Not all cancer patients, however, experience significant distress, leading to 
investigation into factors impacting on psychological adjustment.  Studies have focused on 
both  psychological  and  social  factors  in  addition  to  demographic  and  medical/disease 
related factors, with some implicating a more prominent role of psychological factors in 
adjustment [7-10].   
 
Emotional Expression and non-expression in breast cancer populations 
One psychological construct that has received attention in research relating to both cancer 
and other chronic illness populations is emotional expression.  Several studies have pointed 
to  higher  levels  of  emotional  suppression  in  patients  with  cancer  [11-13],  with  some 
researchers proposing that it has a role in influencing the onset and progression of cancer 
and  survival  outcomes  [14,15,16].    However,  a  more  recent  study  by  Graves  and 
colleagues  between  cancer  “survivors”  and  healthy  controls  found  no  difference  on 
measures of emotional expression [17].  Similarly, Servae et al found no differences in   9 
levels  of  emotional  expression  per  se  but  that  those  with  breast  cancer  reported  more 
ambivalence towards emotional expression compared with controls [18].  It would seem 
that  the  association  between  the  cancer  experience  and  emotional  expression  remains 
equivocal and Graves et al suggest that this is likely to be due to methodological, statistical 
and conceptual differences between studies.  Nevertheless, on the premise that there may 
be some association between breast cancer and emotional expression, within the evolving 
research into psychological factors and psychological adjustment, several researchers have 
investigated whether this  is  one such associated variable.   Indeed, with the belief that 
emotional expression is “good” for psychological adjustment, intervention studies utilising 
it as  a component have also  been developed with  some, but not consistently, reported 
improved outcomes [19,20].  
 
Constructs of emotional expression and non-expression 
Studies investigating the general concept of emotional expression and its associations with 
psychological adjustment in patients with cancer have utilised a number of overlapping but 
distinct psychological constructs.  In reviewing the literature in this area, it is important to 
consider first the constructs they are reporting to measure.   
One  conceptualisation  of  emotional  non-expression  has  been  referred  to  as  “emotional 
suppression”.  This  term  has  been described as  involving a  conscious effort  to  inhibit 
expressive  elements  of  emotional  experiences  [21].    An  example  of  this  might  be 
somebody remaining outwardly calm while being churned up with anger inside.
I  This 
latter description has also been referred to as  “emotional inhibition”.   A related concept 
has been that of “emotional control”, likewise referring to a tendency for individuals to 
control the expression of emotions [23].  The use of these three terms in the literature 
appears  to  be  interchangeable  with  studies  purporting  to  be  investigating  emotional 
suppression or emotional inhibition using measures designed to measure emotional control.  
A  more  distinct  form  of  non-expression,  termed  Alexithymia,  refers  to  a  deficit  in 
expressing emotions  and identifying feelings  in the self and others  [24].  While some 
researchers  have  focused  on  the  non-expression  of  emotions,  others  have  taken  an 
“expression  approach”,  focusing  on  measuring  the  active  expression  of  emotions.  
Although  often  not  referred  to  by  investigators  in  the  area,  a  distinction  should  be 
acknowledged between emotional expression defined as spontaneous venting of negative 
                                                 
I Emotional suppression here, and throughout the text, refers to the suppression of emotional expression as 
opposed to the suppression of the experience of an emotion as the term has been used elsewhere [22].    10 
emotions and as a cognitive process involving verbalisation and communication of inner 
emotional states [25].    
Considering the expression of separate emotions 
Investigators  often  refer  to  a  general  tendency  towards  emotional  expression  or  its 
suppression,  this  being  particularly  evident  in  research  on  interventions  incorporating 
emotional expression.  However, as is highlighted by Schlatter et al, different emotions 
may  be  linked  with  distinctive  motivational,  psychophysiological  and  behavioural 
processes  and  it  is  likely  that  their  suppression  will  have  different  influences  on 
psychological  adjustment  [21].    As  such  a  number  of  studies  have  investigated  the 
expression of different emotions in addition to the general expression of emotion.  
   
The present review 
In 2002 Panagopoulou et al conducted a meta-analysis reviewing the effects of emotional 
expression in chronic diseases [25]. The report aimed to identify the differential effect of 
emotional expression and non-expression on the course and adaptation to chronic disease.  
A weak but significant association was found between increases in psychological distress 
and  emotional  non-expression,  but  the  inverse  relation  was  not  present  for  emotional 
expression.    The  authors  highlighted  that  future  research  should  focus  on  longitudinal 
designs  exploring  effects  of  emotional  expression  on  the  psychological  adaptation  to 
chronic disease and that the implications of emotional expression in the course of various 
forms of medical treatment should be explored. A limit to this review was that it did not 
delineate potential differences in the relation of the expression of separate emotions and 
their association with psychological adjustment. 
A number of studies have been conducted since Panagopoulou‟s report, with a proportion 
incorporating  a  longitudinal  element  to  their  design.    Further,  while  research  has 
traditionally  used  self-report  as  a  measurement  of  emotional  expression,  with  the 
acknowledgement of potential limits to this, use of other attempts to measure this construct 
has emerged.  It was therefore considered timely to review the literature in this area as it 
stands, with a focus on cancer populations.  
Aims 
 
The  present  review  aims  to  establish  findings  on  the  association  between  emotional 
expression/non-expression and psychological adjustment in patients with a diagnosis of 
cancer  by  summarising  and  evaluating  relevant  studies  in  this  area.    The  review   11 
incorporates  research  from  both  the  non-expression  and  expression  approach, 
acknowledging the conceptual differences between the two.  For conciseness, however, the 
term  emotional  expression  will  be  used  to  incorporate  the  two  distinct  approaches 
simultaneously other than where the distinction is required for comparison purposes.  In 
light  of  the  literature  and  conceptual  considerations  outlined  above,  an  initial  general 
question emerges followed by three specific questions:     
 
Research Questions  
1)  What  is  the  evidence  for  an  association  between  emotional  expression  and 
psychological adjustment in people with cancer?  
2)  Are  there  differential  relationships  between  the  different  concepts  of  emotional 
expression and their association with psychological adjustment?  
3)  Is the expression of different emotions differentially associated with psychological 
adjustment? 
4)  How do the results of studies using self-report measures of emotional expression 
compare to those utilising other approaches to its measurement?    
 
Methods 
 
Search strategy 
To identify potentially suitable studies the following electronic databases were searched 
from start of indexing to June 2011:  Ovid Medline, Embase, Psychinfo and All EBM 
Reviews.  Limits were set on search terms to include „English language‟, „human‟ and 
„adults >18years‟.   
The search terms used were:  
1.  [cancer*] OR [neoplasm*] OR [tumo?r] or [carcinogen*] 
2.  emotion*  adj2  [inhibit*  or    suppress*  or  express*  or  control*  or  repress*  or 
regulat*] OR [alexithymia] 
3.  [distress*] OR [stress] OR [mood] OR [depress*] or [anxiety*] OR [wellbeing] OR 
[mental health] OR [adjustment] OR psychological adj2 [response* or symptom* 
or morbid* or outcome*]    12 
The results  of these searches  were then  combined using the  Boolean operator  „AND‟.  
Search terms were also mapped onto relevant subject headings.   
 
Inclusion/exclusion criteria 
Cancer populations do not necessarily represent a homogenous group with the experience 
of each type of cancer bringing its unique set of stressors, however it was deemed that 
there are certain common experiences across cancer groups allowing for consideration of 
the  population  as  a  whole.    Further,  there  is  evidence  to  suggest  that  levels  of 
psychological distress do not necessarily differ according to cancer type [26].  The primary 
focus  of  this  review  was  to  question  the  association  between  measures  of  emotional 
expression and psychological adjustment to cancer.  There were a number of studies that 
explored relationships between these two variables to some degree, but that did not quite 
report on this specifically.  For example, studies evaluating psychological interventions 
which include emotional expression as a treatment component were excluded because it is 
not possible to separate out the specific effects of emotional expression from other aspects 
of  treatment.    Those  studies  investigating  emotional  expression  as  a  moderating  or 
mediating variable of the association between two other variables were also excluded on 
the basis that inclusion of these studies would arguably result in the scope of the review 
becoming  too  broad,  with  difficulties  arising  in  the  cross-comparison  of  findings.    In 
operationalising psychological adjustment, studies were included if they included indices 
of  positive  adjustment  such  as  positive  affect  and  well-being  and  negative  adjustment 
including psychological symptoms such as general mood disturbance, distress, anxiety and 
depression.  Quality of life was considered too broad a construct incorporating social in 
addition to psychological concepts and, therefore, studies investigating its measurement 
were excluded.  Finally, it was deemed important that studies investigated the association 
of  emotional  expression  with  psychological  adjustment  as  opposed  to  its  association 
relative to other coping styles.   In view of these considerations, all studies obtained via the 
electronic search were examined for inclusion in relation to the following criteria:  
Inclusion criteria   
1.  Studies that include a cancer population (aged 18 years or over)  
2.  Studies  investigating  an  association  between  emotional  expression  and 
psychological adjustment    13 
3.  Studies  which  include  a  measure  of  emotional  expression  as  an  independent 
variable  
4.  Studies  which  include  a  measure  of  psychological  adjustment  (e.g. 
depression/anxiety, mood disturbance, distress) as a dependent variable   
5.  Studies published in a peer-reviewed journal article written in English 
 
Exclusion criteria  
1.  Studies evaluating psychological interventions including emotional expression as a 
component which may impact on psychological adjustment to cancer 
2.  Studies investigating emotional expression as a moderating or mediating variable 
between another construct and psychological adjustment. 
3.  Studies investigating quality of life as a general concept 
4.  Studies including emotional expression as a coping style compared to other coping 
styles as opposed to measuring levels of emotional expression   
5.  Review  articles,  single  case  studies,  dissertation  abstracts,  book  chapters  and 
conference proceedings  
 
Results 
 
The electronic search yielded a total of 1736 articles once duplicates were removed.  1432 
articles were deemed unsuitable and excluded on the basis of reading the title alone.  On 
reading the abstracts of the remaining 304 articles, a further 281 were excluded.  Full text 
articles of the resulting 23 studies that were potentially suitable for review were obtained, 
of  which  15  met  criteria  for  inclusion  in  this  review  (See  Appendix  1.2  for  articles 
excluded at this stage).    Reference and citation lists for these 15 articles were searched to 
ensure no appropriate studies had been missed.  Finally, the content‟s pages of key journals 
including  Psycho-oncology  and  Health  Psychology  were  hand  searched  and  this  also 
identified no further articles.  See Figure 1.1 for a description of the search process.  Of the 
15 articles considered for review, findings from the same cohorts were used in the three 
studies by Iwamitsu et al [27-29].   Owen et al and Cordova et al also reported findings 
drawn from the same research pool [30,31].  To be comprehensive, all studies will be 
included in the present review but will be reviewed together.   14 
Assessment of methodological quality 
A quality rating scale was devised for the purpose of this review, using and adapting items 
from  the  SIGN  50:  a  guideline  developer‟s  handbook  [32].    This  scale  covered  the 
following  areas:  study  aims  and  objectives,  design,  participant  recruitment,  outcome 
measurement, participant characteristics, statistical analysis and results (see Appendix 1.3).  
A score of 0, 1 and for certain items 2 could be allocated depending on the degree to which 
each aspect of methodology was met and a total of 21 points could be awarded.  Papers 
received a rating of “high” if 75% of this score was achieved; “medium” if between 50 and 
75% was obtained and “low” if less than 50% was acquired.    Articles reporting findings 
from the same cohort were considered together for a combined methodological quality 
rating to represent the study as a whole.   
 
Reliability of quality rating 
Fifty  percent  of  studies  were  randomly  selected  and  independently  rated  by  another 
researcher using the same rating scale.  There was > 95% agreement between raters and 
discrepancies were resolved via a meeting to discuss and review disagreements.  
 
Review of findings 
Table 1.1 presents data extracted from each study to facilitate comparisons across study 
design, methodology, psychological construct and measurement, main findings and other 
aspects deemed important and relevant for the current review.  The narrative review below 
aims to provide an initial summary of the studies selected, followed by a distillation of the 
overall findings and a consideration of what each study contributes in reference to the 
research  questions.    To  avoid  repetition,  the  studies  utilising  self-report  to  measure 
emotional expression will be considered followed by a separate section reviewing findings 
in relation to studies using other approaches. 
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Summary of studies  
The total sample size of the studies was 1281 (range of n =  21 – 359).  With regards to 
cancer  type,  nine  studies  focused  on  breast  cancer  patients,  one  study  investigated  a 
heterogeneous cancer population (mixed gender), one study confined its investigation to 
women  with  gynaecological  cancers  and  one  looked  at  female  heterogeneous  cancer 
“survivors”.  Thus only one study included males [30,31].  In terms of design, five studies 
were cross-sectional and seven included a longitudinal component.  The majority of the 
studies utilised self-report questionnaires to measure emotional expression, with one study 
using linguistic text analysis and one drawing on both methodologies.  Table 1.1 outlines 
the constructs of emotional expression and psychological adjustment referred to by each 
study.  Emotional expression was investigated as a general concept in ten of the studies 
with six also investigating the expression of separate emotions.  According to the criteria 
defined, six studies were rated as high with the remaining six rated as medium in quality.   
 
Associations between emotional expression and psychological adjustment 
Emotional expression  
The  two  studies  investigating  emotional  expression  found  an  association  with 
psychological adjustment.     
Manne  and  colleagues  [33]  conducted  a  longitudinal  study  investigating  the  impact  of 
positive emotional expressivity on psychological adaptation among women diagnosed with 
gynaecological  cancers  (see  Table  1.1).    Having  a  stronger  tendency  toward  positive 
emotional expressivity at baseline was associated with higher positive affect whilst a lower 
tendency was associated with more depressive symptoms.  Both effects remained stable 
throughout the subsequent 9 months in that although emotional expressiveness predicted 
initial psychological status, it did not predict rate of change in affect.  Further to being 
rated as high according to the quality rating scale, an additional strength of this study is 
that it looks at mental wellbeing as well as mental ill-health which the rest of the articles 
focus solely on.  Psychological adjustment has also been investigated over time rather than 
at one time point, acknowledging the dynamic nature of adjustment to this chronic disease 
with stressors in relation to both illness symptoms and treatment procedures.  A limitation 
is that the participants are drawn from a larger psychological intervention trial which may 
have resulted in a sample that was biased toward psychologically minded women who 
were  more  willing  to  participate  in  psychological  interventions.    A  methodological   23 
weakness common to all studies in this review is that no power calculation was used to 
justify the sample size obtained.  
In another longitudinal study, Stanton et al investigated psychological adjustment to breast 
cancer [34].  Greater use of coping through emotional expression, measured within 20 
weeks following medical treatment, was associated with lower psychological distress three 
months later.   Stanton et al‟s study was also rated as high, one of the strengths being that 
the  authors  statistically  controlled  for  age,  other  coping  strategies  (e.g.  avoidance, 
problem-focused coping, spiritual coping and seeking social support) and initial levels of 
psychological adjustment, with the significant effect remaining.  The authors acknowledge 
that the generalisability of these findings is limited to early stage breast cancer patients and 
to the period after termination of primary medical treatments.  The study also utilised a 
self-report measure that was not used in any of the other studies in this review leading to 
limitations in its comparability to other research findings.     
 
Emotional non-expression 
A total of six studies found an association between constructs of emotional non-expression 
and psychological adjustment, with two studies reporting no such relationship.   
As  Table  1.1  shows,  Watson  et  al‟s  1991  study  investigating  the  association  between 
emotional control, adjustment to cancer and levels of anxiety and depression in a sample of 
women recently diagnosed with breast cancer had the largest sample size of the studies 
selected for review and was rated as high [23].  Watson et al used the Courtald Emotional 
Control Scale (CECS), the Hospital Anxiety and Depression Scale (HADS) and the Mental 
Adjustment  to  Cancer  Scale  (MAC).    The  CECS  was  developed  with  a  population  of 
patients awaiting breast biopsy.  It provides a total emotional control score in addition to 
separate indices of the control of anxiety, depression and anger [35].  The measure has 
been used extensively in cancer research with good psychometric properties demonstrated 
with this population (e.g. Schlatter et al [21], Classen et al [36], Owen et al [30], Ho et al 
[37], Iwamitsu et al[28] and Ando et al[38] in this review).  This leads to the advantage of 
being able to compare the outcomes in this report with results of other studies in this area.  
Indeed, as can be seen in Table 1.1, 8 of the 12 studies reported in this review used this 
measure.  The HADS has the benefit of being specifically designed for medical patients 
and  has  been  validated  for  use  with  cancer  populations  and  the  MAC,  as  the  name 
suggests, was developed and validated on a population with various cancer types.  Further 
to looking at associations between emotional control and the other two variables, it was   24 
specifically hypothesised that there would be an association between emotional control and 
feelings of helplessness as measured by the MAC and that helplessness would, in turn, be 
associated with more symptoms of depression.  A tendency towards emotional control was 
indeed associated with helplessness and helplessness was associated with more symptoms 
of both depression and anxiety.   Higher levels of HADS anxiety were reported for high 
than  for  low  emotional  controllers,  however  this  difference  was  not  observed  for  the 
HADS depression scores lending some support for the role of helplessness in linking these 
two variables.  
Classen  et  al  investigated  the  association  of  emotional  control  with  psychological 
adjustment in a sample of women with metastatic or recurrent breast cancer finding higher 
levels of emotional control to be associated with greater mood disturbance [36].
  Although 
rated  as  high,  with  clearly  defined  study  objectives  and  sampling  and  the  use  of 
psychometrically sound  measures,  the interpretation  of the results  of this  study has  its 
limits.  The study is of a cross-sectional design whereby no prediction is possible with 
regards  to  whether  emotional  inhibition  predicts  future  adjustment.    A  further 
methodological weakness is that, despite reporting a range of demographic and medical 
variables, none of these were considered as potential confounders in analysis.  There is also 
some confusion over the approach being used to measure emotional expression.  As Table 
1.1  indicates,  the  authors  report  that  psychological  adjustment  is  associated  with 
expressing emotion, however, the CECS, which measures the extent to which individuals 
report controlling the expression of emotions, was used.  Although some items, which are 
reversed when calculating the emotional control score, do reflect emotional expression, 
there are only 5 such items out of 21, indicating a measure of emotional control.  It could 
be argued that a low score does not necessarily relate to active emotional expression which 
is implied by the authors.                
In  the  earliest  study  included  in  this  review,  Grassi  and  Molinari  investigated  the 
relationship between suppression of negative feelings and psychological reaction to cancer 
in a group of breast cancer patients pre-biopsy, a week after mastectomy and six months 
later  [39].    The  CECS  was  used  to  measure  emotional  suppression,  implying  that  the 
authors consider this to be measuring the same construct. Table 1.1 shows this overlap is 
present throughout research in this field, with 5 other studies using the CECS to measure 
emotional suppression.  Indeed, the two terms are used interchangeably by the developers 
of the scale.  Emotional suppression measured before lump biopsy was correlated with 
both depression and hostility at six months.  No such associations were demonstrated at the   25 
two  earlier  points  at  which  psychological  reaction  was  measured  or  with  other 
psychological symptoms of anxiety and somatisation.  This study was rated medium, one 
of its weaknesses being that a number of potential confounding variables were not taken 
into  account  in  analysis  (e.g.  stage  of  disease,  prognosis  and  type  of  therapy).  
Interpretation  of  the  results  is  further  limited  by  a  small  sample  size  with  only  12 
participants remaining at the final 6 month assessment stage.    
Iwamitsu  et  al  investigated  the  relation  between  emotion  suppression  and  emotional 
distress in breast cancer patients, like Grassi et al [39], at different points in the patient‟s 
journey  (see  Table  1.1)  [27-29].    Iwamitsu  et  al  split  their  sample  into  an  emotional 
suppression and an emotional expression group with a cut-off being the median values for 
the total emotional control score of the CECS.  The emotional suppression group reported 
more  depression  and  anger  than  the  emotional  expression  group  at  first  visit,  after 
disclosure of diagnosis and at three months after discharge but not after operation.  This 
study was rated medium, being brought down by a lack of clarity in participant selection 
and characteristics reported.  One of its strengths, however, like Manne et al‟s study [33], 
was its exploration of the dynamic nature of adjustment to cancer and its influences.   For 
the emotional suppression group there were significant differences in the levels of distress 
between different points in time, whereas no such differences were found for the emotional 
expression group.  This indicates a different pattern of adjustment for the two groups.  It is 
also possible that inference could be made in terms of at what stage emotional suppression 
may be particularly detrimental to psychological adjustment and in turn, at what point any 
related intervention may be beneficial.   However, little is made of this finding and its 
potential implications in Iwamitsu et al‟s report.  This particular study was a section of an 
overall research programme comparing breast cancer patients with those whose tumour 
was  discovered to  be benign.   For this  particular analysis, only  fourteen breast  cancer 
patients  were  included  with  seven  in  each  group  and  caution  should  be  made  in 
generalising the significant effects found with such a small sample.  There is also some 
confusion in the approach to the construct of measuring emotional expression that is taken.  
Although the authors refer to findings in relation to emotional suppression, referring to the 
group  with  scores  at  the  lower  end  of  the  CECS  as  “emotional  expressers”  could  be 
misleading for the same reasons outlined in relation to Classen et al‟s study [36].   
In their study of emotional control in Chinese female cancer survivors, Ho and colleagues 
found  that  higher  levels  were  associated  with  perceived  stress,  anxiety,  depression, 
helplessness  and  anxious  preoccupation  [37].      Emotional  control  positively  predicted   26 
stress levels even after the effect of depressed mood was under control.  This study, rated 
as medium, was cross-sectional and as such no causal relationships can be implied.  Also, 
Ho et al did not account for any patient characteristics as potential confounders in their 
analysis despite the variability in age and type of cancer in the sample.  Although not 
longitudinal,  a  unique  contribution  this  study  makes  is  that  it  investigates  “cancer 
survivors” who, defined by the inclusion criteria, have been disease free in the last 5 years.  
Some  insight  is  therefore  provided  as  to  longer  term  adjustment  of  cancer  sufferers.  
However, no information is provided as to how long the participants recruited have been 
disease free.     
Ando  and  colleagues  measured  breast  cancer  patients‟  negative  emotional  suppression 
prior to diagnosis to investigate to what extent it was predictive of psychological distress 
immediately after diagnosis [38].  Like Iwamitsu et al [27-29], Ando et al used the CECS 
to  measure  emotional  suppression  and  the  POMS  for  their  outcome  of  psychological 
distress,  however,  no  significant  effect  was  found.    It  is  possible  that  this  is  due  to 
differences in the use of the measure and analysis.  Ando et al used multiple regression 
analysis with CECS scores entered as possible predictors of total mood disturbance as 
opposed to exploring differences between groups on subscales of the POMS.  Also, there 
was a larger age range in Ando‟s study.  It is difficult to ascertain if any other differences 
lie in the sample characteristics between the two studies as little information is provided in 
Iwamtsu et al‟s report.  Ando et al‟s study was rated as medium.  One weakness was its 
lack of clarity in some areas.  For example, the measure of emotional suppression taken 
prior to diagnosis was taken at “their initial outpatient visit” to a breast clinic but there is 
no indication of at what stage patients are at in the diagnostic process at this point.  A 
further limit of the study in relation to the questions raised in this specific review is that 
psychological  response  was  taken  almost  immediately  after  diagnosis  which  arguably 
represents a more transient affective response that might remit spontaneously as opposed to 
giving an indication of psychological adjustment per se.  Iwamitsu et al‟s study[27-29], 
while also  taking measures  at  this  time, was  not  limited to this  one-off recording.  A 
strength of Ando et al‟s study was that it compared demographics of those taking part and 
those not, in an attempt to ensure that these potential biases were not evident in the sample 
studied.  Mantani et al‟s 2007 study below also accounted for this [24].   
Schlatter  et  al  2010  examined  whether  emotional  suppression  was  predictive  of  mood 
states for breast cancer patients during chemotherapy for breast cancer [21].  Emotional 
suppression was again measured using the CECS, taken at one time point specified as   27 
within 12 weeks of surgery and prior to the onset of chemotherapy.  Mood disturbance was 
then measured on a daily basis for the duration of four cycles of treatment (84 days).  
Measures of mood included anxiety (The Speilberger State-Trait Anxiety Inventory short 
form), anger (The measure of angry mood), and depression (The four-item version of the 
Centre for Epidemiological Studies Depression Scale).  No association was found between 
emotional suppression in general and any of these mood outcomes, however as discussed 
below, Schattler et al also investigated the relation between the suppression of specific 
emotions and mood, where associations were found to be significant.  Schattler et al‟s 
study was rated as high.  A strength, where a number of the studies in this review are 
lacking, is that it considered a number of potential confounding medical variables that 
could  be  associated  with  emotional  suppression,  including  prognostic  status  and  stage.  
However,  it  was  interesting  to  note  that  none  of  these  variables  were  found  to  be 
significantly associated with emotional suppression and their inclusion as covariates in the 
mixed linear model analyses did not alter the patterns of the findings.  One potential limit 
to the study was its use of one- to four-item measures of mood. However, with the multiple 
daily  assessments  being  made,  it  was  deemed  unfeasible  to  use  lengthier  measures.  
Another  caution,  acknowledged  by  the  authors  themselves,  is  that  the  use  of  daily 
measures, whilst enhancing the potential sensitivity in detecting associations of emotional 
suppression with mood, may have increased focus on symptoms and mood in a way that 
could have impacted on the reports of their occurrence and intensity.  A further limit lies in 
the authors‟ use of the data collected.  Although variation in mood over time was explored, 
with anxious mood tending to be elevated at the onset of a cycle and decrease over the 
course  of  the  cycle,  no  attempt  was  made  to  explore  changes  in  mood  in  relation  to 
suppression of emotion.         
The only study investigating the construct of alexithymia was Mantani et al‟s exploration 
into associations between alexithymia and anxiety and depression in postsurgical women 
with breast cancer [24].
  Rated as medium, this cross-sectional study utilised the 20-item 
Toronto Alexithymia Scale (TAS-20).  The TAS-20 includes items rated on a five-point 
scale with a three-factor structure relating to the construct of alexithymia: difficulty in 
identifying feelings; difficulty in describing feelings; externally oriented thinking.  It is 
highlighted by the authors that the TAS-20 has been demonstrated to have high construct 
validity and reliability.  Bringing the rating down, however, is that no reference is made to 
the reliability within this condition-specific population.  The Zung self-rating anxiety scale 
and  Zung  self-rating  depression  scale  are  used,  again  with  no  condition  specific 
psychometric properties reported.  A high degree of alexithymia correlated with a high   28 
degree of patient anxiety but was not related to depression.  Due to the cross-sectional 
nature of this study, it is not possible to determine whether the symptoms of alexithymia as 
measured by the TAS-20 indicate a trait like characteristic or what has been described as a 
“secondary” or  “reactive” alexithymia as a defensive reaction to a stressful event.         
 
Is the expression of different emotions differentially associated with psychological 
adjustment?  
Critique of individual articles is included elsewhere in this review and therefore studies 
investigating the expression of separate emotions will be considered together in this section 
with less reference to the detail of the studies.  All papers using self-report to investigate 
emotional expression confined their analysis to that of general emotional expression and 
therefore this section focuses on constructs relating to emotional non-expression.     
Suppression of anxiety  
A total of four studies reported on the associations between suppression of anxiety and 
psychological adjustment with inconsistent results.  Both Watson et al [23] and Ho et al 
[37]  demonstrated  significant  associations  between  anxiety  suppression  and  greater 
anxiety.  Conversely, Schlatter found that anxiety suppression was associated with lower 
reports  of  anxiety  and  Grassi  et  al  found  no  significant  associations  between  anxiety 
suppression and any psychological symptoms [21, 39].  Iwamitsu et al found that their 
anxiety suppression group did not differ significantly on levels of anxiety compared with 
the anxiety expression group but that they did score higher on the depression-dejection 
scale of the POMS at first visit, after diagnosis and three months after discharge [27-29].  
They also scored higher on the anger-hostility scale after diagnosis and after discharge and 
on the fatigue-inertia scale after diagnosis.     
Suppression of anger 
A confusing picture also emerged from the three studies reporting associations between 
suppression of anger and psychological adjustment.  Anger suppression was associated 
with higher depression in both Schlatter and Iwamitsu‟s studies[21, 27-29].  Iwamitsu et al 
also found that those who suppressed anger had significantly higher scores on the tension-
anxiety  subscale  of  the  POMS  compared  with  those  who  expressed  anger.    However, 
Grassi et al found a negative correlation between amount of anxiety and control of anger, 
before  biopsy,  in  their  study.    Finally,  Grassi  et  al  found  that  control  of  anger  was 
significantly positively correlated with hostility [39].        29 
Suppression of depression  
Finally, five studies investigated suppression of depression symptoms.  Both Ho et al and 
Watson et al reported significant associations between the control of depression and self-
report  of  levels  of  depression  [23,  37].    Interestingly,  Grassi  found  that  whilst  before 
biopsy control of depression was negatively correlated with amount of depression reported, 
one  week  after  mastectomy,  though  not  significant,  there  was  a  trend  in  the  opposite 
direction [39].  Schattler et al found that suppression of depression was associated with 
higher  anxiety  and  finally  Iwamitsu  et  al  found  no  difference  between  the  depression 
suppression and depression expression groups on any measure of psychological adjustment 
[21,27-29].  
 
How do results of studies using self-report measures of emotional expression compare to 
those utilising other approaches to its measurement?     
Owen and colleagues conducted an interesting study investigating the relationship between 
self-report and linguistic indicators of emotional expression and how they both relate to 
adjustment to cancer [30, 31].  Their sample of individuals attending a community cancer 
support group completed the CECS and POMS as measures of emotional suppression and 
mood disturbance.  Participants were also invited to provide a written narrative about their 
cancer experience.  A computerised content analysis program developed by Pennebaker 
and Francis, named the Linguistic Inquiry and Word Count (LIWC) [40], was used to 
measure  emotional  expression  in  this  narrative.    The  program  uses  a  word  counting 
approach comparing each word or word stem identified in a text sample to each of 2,290 
words contained in content-specific dictionaries, including those relating to affective or 
emotional processes.  In justification of its use, Owen et al[30] report that LIWC has been 
shown  to  replicate  a  manual  content  analysis  of  breast  and  prostate  cancer  online 
discussion groups.  They also point to literature evidencing its use in studies demonstrating 
a link between emotional expression and improved physical health outcomes.  Moderate to 
strong positive correlations were demonstrated between scores on the CECS and POMS.  
However,  the  authors‟  hypothesis  that  individuals  who  self-report  lower  levels  of 
emotional suppression would be more likely to evidence emotional expression in written 
cancer narratives was not observed.  Further, linguistic indicators of emotional expression 
were not significantly correlated with mood disturbance.   
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The reports by Cordova et al [31] and Owen et al [30] were rated as high overall.  A 
strength  in  this  research  lies  in  its  attempt  to  compare  two  methods  of  analysing  the 
construct of emotional expression.  The study was also methodologically sound with clear 
aims and hypotheses, a large sample size and consideration of confounding variables.  For 
example, demographic and other personal characteristics of those who chose to provide a 
written cancer narrative and those who did not provide a narrative were considered and the 
groups did not differ with respect to age, gender or indices of socioeconomic status and 
ethnicity, medical factors, time spent using the support group or primary study variables 
indicating that these factors are unlikely to have biased the results obtained.   
Lieberman and Goldstein also used the LIWC as a measure of emotional expression [41]. 
A measure of depression was completed by new members to a breast cancer internet based 
bulletin board.  After 6 months, the measure was repeated and messages during that time 
were collected and analysed for emotional content.  In concordance with Owen et al, initial 
analysis  of  negative  emotions  by  themselves  had  no  predictive  validity  for  change  in 
depression.  However, examining individual dimensions of negative emotional expression 
within the context of cancer, Lieberman et al found that greater expression of anger and 
sadness was  associated with lower depression after six months.  Conversely, the more 
participants expressed anxiety, the higher were depressive scores after 6 months.  Rated as 
medium, one weakness of the study is no clear inclusion or exclusion criteria defined as to 
who was eligible for participation in the study.  Further, as is highlighted by the authors, 
the results are correlational and it is not possible to infer whether the expression of specific 
emotions is causing the changes in distress or rather a manifestation of these changes.  
However, the finding that emotional expression was not associated with depression at time 
1 shows that there is at least a degree of change occurring in association with emotional 
expression.         
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Discussion 
 
This  review  aimed  to  address  the  general  question  of  whether  there  is  an  association 
between  emotional  expression  and  psychological  adjustment  in  cancer  patients.  More 
specific enquiry was made regarding the concepts of emotional expression, the expression 
of separate emotions and the measurement of this construct.  Main conclusions in relation 
to  these  questions  are  made  along  with  a  consideration  of  limitations  to  the  research 
reviewed, recommendations for future research and clinical implications.     
 
Associations between emotional expression and psychological adjustment 
The majority of studies found a significant association between emotional expression and 
psychological adjustment.  Including both those studies using self-report and those using 
linguistic indicators of emotional expression, a total of 10 studies found an association, 
with the direction of this relationship being consistent across studies. There was also some 
evidence for the change of the association of emotional expression with psychological 
adjustment  over  time  with  two  studies  indicating  that  emotional  suppression  was 
associated with psychological distress at 3 or 6 months follow-up but not shortly after an 
operation [27-29, 39].  Further, it was found that whereas variation in levels of distress 
over time emerged for Iwamitsu‟s group of “emotional suppression” patients, levels of 
distress remained constant for the “emotional expression” group.    
 
Relationships between the different concepts of emotional expression and their 
association with psychological adjustment 
Although the two studies finding no association were investigating emotional suppression, 
with  the  remainder  of  the  studies  using  this  construct  finding  an  association  with 
psychological adjustment it would appear that, based on the review of the studies included 
in  this  report,  there  are  no  apparent  differences  between  the  two  main  approaches  to 
measuring emotional expression and its association with psychological adjustment: that is, 
attempts  to  suppress,  inhibit  or  control  emotional  expression  is  linked  to  poorer 
psychological  adjustment  and  the  expression  of  emotions  is  associated  with  better 
adjustment.  The one study investigating the construct of alexithymia also found that this 
was  associated  with  poorer  psychological  adjustment  [24].    Despite  the  complex  and 
diverse reasons behind a lack of emotional expression, be it a deficit, a deliberate effort to 
control the expression of emotions or some other mechanism that is perhaps less conscious, 
it would appear that it is associated with poorer psychological adjustment.  However, this   32 
would be a bold statement to make with only three studies reporting a measurement of 
emotional expression, one of which using a measure of emotional control.  It should also 
be highlighted that even if this claim was proven valid, it is important to examine why 
people do not express their emotions, particularly in the development of psychological 
interventions based on this association.  Also, calculating combined effect sizes in their 
meta-analysis, Panagopoulou et al found a weak significant association between increases 
in psychological distress and emotional non-expression but that the inverse was not true for 
emotional expression [25]. 
 
Is the expression of different emotions differentially associated with psychological 
adjustment? 
With  several  studies  finding  the  suppression  of  certain  emotions  but  not  others  being 
linked with poorer psychological adjustment, there is at least some suggestion that there is 
a differential association at play.  Also of interest is that the suppression of one emotion 
has been linked to the report of another emotion.  For example, both Schlatter et al [21] 
and  Iwamitsu  et  al  [27-29]  found  anger  suppression  to  be  associated  with  depression.   
Although there are some consistencies in the findings, there are also disparities that cannot 
be  ignored  and  as  such  no  confident  claims  can  be  made  that  the  suppression  of  one 
emotion is or is not linked to a particular psychological outcome.  One interesting finding 
was  that  Grassi  et  al  [39]  found  that  control  of  depression  was  correlated  with  lower 
depression  before  biopsy  but  the  trend,  although  not  significant,  was  in  the  different 
direction at a later stage, after mastectomy.  This implies a complex interplay between 
emotional expression and psychological adjustment which varies according to context and 
could  also  account  for  differences  in  findings  across studies.   Another explanation for 
discrepancies  in  the  findings  could  be  in  the  scales  used  to  measure  constructs  of 
psychological adjustment.  To illustrate, Ho et al [37] and Watson et al [23] both used the 
HADS to measure anxiety and were congruent in reporting an association between higher 
scores on this subscale and control of this emotion, also measured by the same scale.  The 
studies which did not report such outcomes utilised different measures of anxiety (see 
Table 1.1).  
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Studies using self-report measures of emotional expression compared to those utilising 
other approaches to its measurement 
With only two studies  utilising measures  other than self-report, there is  a limit  to  the 
conclusions which can be drawn in relation to this final question.  However, Owen et al‟s 
[30, 31] finding that lower levels of emotional suppression according to self-report were 
not associated with evidence of higher levels of emotional expression in written narratives 
provides some considerations for the use of Pennebakers‟ LIWC in measuring emotional 
expression.  One possibility is that although a measure of emotional expression is obtained, 
it does not tap into the construct of emotional suppression.  This makes sense in that the 
conscious suppression of emotions as opposed to the mere lack of expression of emotions 
is likely to require some form of insight provided by the person being “observed” that 
would be brought about by self-report but not necessarily in LIWC.  Another interpretation 
is that perceptions of one‟s ability to regulate emotion through emotional expression in 
everyday situations is not relevant to how they might perform in the specific circumstances 
created  in  a  narrative  writing  task.    Alternatively,  linguistic  indicators  of  emotional 
expression as measured by the LIWC are perhaps not sufficiently sensitive to detecting 
emotion expression in this population.  The latter argument is given weight by the finding 
that  linguistic  indicators  in  this  study  were  not  significantly  correlated  with  mood 
disturbance, where this association is largely found elsewhere.   
It is difficult to compare directly the results of Lieberman‟s [41] study of the expression of 
separate emotions to those using self-report as the studies using self-report purport to be 
measuring emotional suppression of separate emotions.  It is interesting to note, however, 
that greater expression of anger as measured in this study was related to lower depression 
and greater control of anger was related to higher depression in two self-report studies.    
 
Critique of methodology in studies 
Studies varied in their methodological quality according to the rating used with half rated 
as high and the other half medium.  Promisingly no studies were rated as low.  In addition 
to  weaknesses  highlighted  throughout  this  review  (e.g.  lack  of  consideration  of 
confounding variables, justification of sample size), a number of limits were evident that 
the rating scale used was not sensitive to.  One of the weaknesses in this area of research is 
a  heavy  reliance  on  self-report  in  the  literature  and  the  potential  problem  of  common 
method variance.  While these measures are important in gaining valuable information on 
individuals‟  perceptions  of  their  expressions  of  emotions,  there  are  certain  cognitive   34 
memory and social desirability biases in relation to their use.  As is indicated, there may be 
a discrepancy between this subjective perception and more objective measures.  It is thus 
difficult to ascertain the construct validity of such measures.  Moreover, Panagopoulou et 
al  argue  that  it  is  difficult  for  respondents  to  distinguish  between  items  referring  to 
expressing and experiencing distress and the confounding effects become stronger when 
the levels of psychological distress are increased [25].  There is also a lack of clarity in 
reference  to  the  conceptually  distinct  constructs  of  emotional  expression,  particularly 
where  measures  of  emotional  control  were  utilised  in  studies  reporting  on  emotional 
expression as opposed to non-expression.  This prevents clear interpretation of findings in 
the  literature  as  a  whole.    Another  limit  is  that,  although  seven  of  the  twelve  studies 
incorporated a longitudinal element to their design, no conclusions can be drawn with 
regards to long-term adjustment with the longest follow-up assessment made nine months 
after baseline.  Finally, a limit in terms of scope of the literature is the lack of investigation 
of emotional expression and its association with psychological adjustment in men with 
cancer.  Although Cordova et al [31] found no differences between men and women on 
emotional suppression and mood disturbance, it is noted that over 70% of the sample were 
females and further investigation with this population to replicate this finding is required to 
substantiate this claim.  These shortcomings lead to several suggestions for future research 
outlined in the Research Agenda below: 
 
Clinical implications 
 
 
Research Agenda:  
  Further research evaluating behavioural and other indices of emotional 
expression and their relation to self-report.  For example,  use of objective 
measures such as peer reports, behavioural coding of emotional expression 
in addition to further refinement of linguistic text analysis in cancer 
populations 
  Use of longitudinal studies with extended follow-up periods to investigate 
long term psychological adjustment in relation to emotional expression 
  Further research into the association between emotional expression and 
psychological adjustment at different time points over the course of 
diagnosis and treatment with larger sample sizes.   
  Expansion of research to include measurement of emotional expression and 
its association with psychological adjustment in men 
  Continued research into association between expression of separate 
emotions and adjustment 
      35 
Clinical implications 
Despite limits relating to both the studies evaluated and the conclusions that can be drawn, 
there are certain implications for health professionals.  Encouraging and facilitating cancer 
patients to identify and express both negative and positive emotions is likely to improve 
psychological adjustment.   Indeed emotional expression is included as a component in 
interventions for cancer patients such as Adjuvent Psychological Therapy [42] and specific 
techniques such as expressive writing [43] have been used with this population [44, 45].  
Developments  with  other  clinical  populations  such  as  the  use  of  spoken  emotional 
disclosure methods with rheumatoid arthritis [46] and the integration of expressive writing 
techniques  with  mindfulness/awareness  techniques  and  exercises  to  help  patients  with 
chronic pain to identify, express and integrate emotions [47] could also be considered with 
cancer patients.   In targeting the facilitation of emotional expression, it may be beneficial 
for clinicians to focus on the specific emotions being suppressed and how this may be 
affecting their psychological  adjustment.    In  addition,  it is  worth  considering the time 
points  at  which  emotional  suppression  may  be  impacting  negatively  on  psychological 
adjustment  and  to  be  aware  that  emotional  expression  may  be  associated  with  poor 
psychological adjustment several months after surgery even if it is not evident at an earlier 
stage.                   
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Lay Summary 
The  main  aim  of  this  study  was  to  investigate  psychological  characteristics  in  adults  who 
experience sleepwalking or night terrors, otherwise known as nREM parasomnias.  A group of 
people who currently experience these events were compared to a group of people with insomnia 
and a group of “good sleepers” in a questionnaire based study.  Participants answered questions in 
relation  to the  following  psychological  responses:  emotional  inhibition;  worry;  rumination  and 
arousability (i.e. how much they are aroused either physically or mentally in different situations).  
It was found that the group with nREM parasomnias experienced higher levels of all of these 
measures than the good sleepers.  Those with insomnia were also found to have higher levels on all 
of these measures apart from rumination.  Overall these findings mean that psychological factors 
may play a part in the presentation of sleep walking and night terrors and it is worth continuing to 
explore this in further research.  If findings like these are replicated in future research then, it is 
worth  considering  developing  psychological  interventions  to  help  sufferers  for  whom  such 
experiences are having a negative impact on their lives.      
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Abstract 
Background: Little is known about the psychological characteristics of adults presenting 
with nREM parasomnias.  Research indicates that a common factor associated with their 
onset is stress.  Early studies suggest that adults experiencing such phenomena may be 
emotionally inhibited but no research has directly investigated this.   Understanding of 
insomnia and its associated psychological factors is more developed with several studies 
finding a relationship with both worry and rumination.  The role of somatic and especially 
cognitive arousal has also been emphasised.               
 
Methods:  The present study aimed to investigate these psychological factors in adults who 
experience nREM parasomnias.   148 adults were recruited with the index group of interest 
being the nREM parasomnia (nREMp) group (n = 48), a parallel sleep disorder group of 
people with Insomnia (n = 50) and a control group of good sleepers (GS) (n = 50).  The 
three  groups  were  compared  for  differences  on  self-report  measures  of  emotional 
inhibition, worry, rumination and arousal.        
 
Results:  Compared with the GS group,  significantly higher levels on all psychological 
variables were reported by the nREMp group and on all but rumination by the Insomnia 
group.  The Insomnia group scored higher than the nREMp group on cognitive arousal 
with no other differences found between these two sleep disordered groups.     
 
Conclusions: Preliminary evidence is presented for the influence of psychological factors 
in nREM parasomnias.  Further studies are required to replicate and extend these findings.  
There  are,  however,  implications  for  the  development  and  evaluation  of  psychological 
interventions which could prove a viable alternative treatment option for such clients in 
clinical settings.        
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Introduction 
 
What are nREM parasomnias? 
The  group  of  sleep  disorders  collectively  known  as  parasomnias  are  characterised  as 
undesirable  physical  or  behavioural  phenomena  occurring  during  the  sleep  period.
1 
Common parasomnias include those that occur in REM (Rapid Eye Movement) sleep such 
as nightmare disorder and REM sleep behaviour disorder, and Non REM (nREM) sleep-
arousal  disorder.
1  The  present  study  focuses  on  nREM  sleep-arousal  disorders,  also 
referred to as “nREM parasomnias”.  nREM parasomnias tend to arise from stages 3 and 4 
of nREM sleep (slow  wave sleep) and during the first  third of the sleep cycle.
2  The 
episode generally occurs in the first half of the night and the individual has near-total or 
total  amnesia  following  the  event.
3  The  main  phenomena  within  this  category  of 
parasomnia are night terrors and sleepwalking.
2  Night or “sleep” terrors are episodes of 
extreme terror associated with intense vocalisation and body motility and high levels of 
autonomic discharge.
4  The individual is completely fixated on this frightening experience 
and,  whilst  awareness  is  restricted  as  such,  cannot  be  reassured.
5  Sleepwalking  or 
“somnambulism”  is  characterised  by  ambulatory  activity  during  nREM  sleep.  
Sleepwalking and night terrors have been reported in some cases to occur together.
6 
 
Night terrors and sleepwalking are described in the International Classification of Diseases 
(ICD-10)  and  the  International  Classification  of  Sleep  Disorders  (ICSD2).
7,  8    More 
specific  forms  of  nREM  parasomnias  have  also  been  reported  including  sleep-related 
eating disorder and sleep sex.
2     
 
Prevalence of nREM parasomnias 
Episodes of night terrors and sleepwalking are more common in children than adults and 
usually decrease in frequency with increasing age.
2  However, their prevalence in adults 
has been found to be higher than is often assumed.
9  In a study based on self-report data in 
a sample from the UK general population, Ohayon and colleagues found that night terrors 
were  reported  by  2.2%  of  participants  and  sleepwalking  by  2%  compared  with  recent 
estimates  of  a  14.5  and  39.8  %  prevalence  rate  estimated  for  night  terrors  and  sleep 
walking  respectively  in  young  children.
6,10   No  gender  differences  were  indicated  in 
Ohayon et al‟s study, however other studies have reported that sleepwalking is around 
twice as common in males compared to females.
5  nREM parasomnias have also been 
found to have a genetic basis and familial pattern.  Specifically, the HLA gene DQBI has   46 
been reported to be present in 35% of sleepwalkers compared to 13.3% of normal controls 
with the presence of nREM parasomnias in a first degree relative increasing the chances of 
developing the disorder by a factor of 10.
11  
 
Why study nREM parasomnias? 
While the majority of people who experience nREM parasomnias will not come to the 
attention of researchers or sleep professionals, for some there is a great desire for help in 
reducing  or  eliminating  their  occurrence  due  to  the  distress  and  potential  risk  caused.  
Sleep can be interrupted which, as  with  other sleep disorders, leads  to  a disruption in 
daytime  functioning.    Behaviour  related  to  the  disorder  can  also  cause  harm  and 
inconvenience to the self and/or others, impacting significantly on the individual‟s quality 
of life. Those afflicted can engage in complex motor activities including attempting to 
unlock locks, cook, climb out of windows, drive and engage in physically violent acts 
against others. 
3,2 (see Appendix 2.2 for case illustration).  In severe cases incidents of 
homicide, filicide and suicide have been reported.
9  Increasingly, experts in the field of 
these disorders are asked to give their opinion in legal cases where violent or injurious 
behaviours have purported to have arisen from sleep.
12   
 
Unfortunately, the evidence base for effective psychological and medical interventions is 
lacking.  In a recent systematic review, Harris and colleagues reported a great need for 
adequately powered randomised controlled trials of treatments to better inform clinicians.
13 
In order to develop psychological interventions, there needs to be investigation into the 
characteristics of people experiencing these phenomena and the possible factors that may 
predispose, precipitate and perpetuate these behaviours.   
 
What do we know about nREM parsomnias and when they occur? 
A common factor found to be associated with the onset of nREM parasomnias is stress.
11  
In  Ohayon  and  colleagues‟  aforementioned  study,  the  group  who  experienced  nREM 
parasomnia reported higher rates of stressful life events and mental stress in the past year 
compared  with  those  experiencing  no  such  behaviour.
6  Sleep  deprivation  and  alcohol 
consumption have also been linked  to their occurrence.
11   
There has been some investigation into a possible relationship between psychopathology 
and nREM parasomnias.  Interestingly, Kales and colleagues found more intense clinical 
manifestations and high levels of psychopathology in adult-onset sleepwalkers compared 
with adults who had been sleepwalkers in childhood.
14  Ohayon found a high percentage of   47 
subjects with nREM parasomnias had concurrent mood or anxiety disorders.  Specifically, 
mood  disorders  were  found  in  30.4%  of  those  with  night  terrors  and  14.6%  with 
sleepwalking compared with only 5.7% in healthy subjects.
6  
 
Crisp and colleagues investigated personality and psychoneurotic characteristics of adults 
with  either  sleepwalking  or  night  terrors.    A  normal  psychological  profile  apart  from 
exceptionally high scores on hysteria, was demonstrated in both groups and high anxiety 
scores in the night terrors group.
15  Crisp notes that questions within the hysteria scale most 
often responded to positively by those with night terrors included items relating to being 
excessively  emotional,  but  that  few  of  these  patients  displayed  such  behaviour  in 
wakefulness.
6  In reviewing literature on night terrors, Carlson et al similarly point to a 
tendency of people with night terrors to “react with fear and apprehension and inhibit 
outward expression” (Carlson et al 1982, p462).
16  Concurrent with this is the finding that 
sleepwalking and night terrors are more common in good, compliant children who do not 
show  their  emotions.
17  These  early  suggestions  about  the  potential  importance  of 
psychological factors have not been followed up in research.  For example, there has been 
no research directly investigating emotional expression in adults presenting with nREM 
parasomnias. 
 
Turning to insomnia 
When considering research into sleep disorders, one turns to the topic of insomnia and 
finds a greater understanding of its  associated  factors.   Increasing age, female  gender, 
psychiatric, in particular anxiety and depression, and medical disorders are all consistently 
found to be risk factors for insomnia.
18  As is the case with nREM parasomnias, various 
studies have shown that stressful life events are often associated with insomnia.  More 
specifically, Morin and colleagues reported that the frequency of daily minor stresses was 
comparable for good and poor sleepers but the perceived impact of those stressors was 
higher for insomniacs, suggesting that it is the appraisal process rather than stress itself that 
is implicated in the presentation of insomnia.
19 
 
Incorporating  established  links  between  insomnia  and  stress,  a  number  of  cognitive 
behavioural models concerning factors that predispose, precipitate and perpetuate insomnia 
have  lead  to  the  development  of  psychological  interventions  and  subsequent  outcome 
studies.  Harvey‟s cognitive model posits that, in the context of a life stressor cognitive 
arousal  in  the  form  of  rumination  and  worry  predisposes  the  individual  to  insomnia.  
Chronic insomnia can ensue with a shift in the content of cognitions to concerns regarding   48 
the inability to sleep and consequences of sleep loss which, along with other cognitive 
processes such as selective attention for sleep-related threats and distorted perceptions of 
daytime deficits, serves to maintain insomnia.
20  In support of this model, several studies 
have found an association between both rumination and worry and poor sleep.
21-23  Other 
cognitive processes have also been implicated to have a role in insomnia.  For example, 
Vela-Bueno found emotional inhibition to act as a mediating factor between rumination 
and sleep quality.
24   
 
The  central  tenet  in  Harvey‟s  model  lies  in  cognitive  arousal.    An  alternative, 
neurocognitive  model,  delineates  arousal  along  the  three  intersecting  dimensions  of 
somatic, cognitive and cortical arousal.
25  Where somatic arousal is thought to be more 
characteristic of acute insomnia, increased cortical arousal is proposed to be a conditioned 
response occurring around sleep onset and/or during the sleep period following repeated 
pairings of sleep related stimuli with insomnia related wakefulness.  It is suggested that 
this cortical arousal acts as the biological precipitant to cognitive arousal in the context of 
chronic insomnia and contributes to sleep continuity disturbance through enhanced sensory 
processing, enhanced information processing and long term memory formation. Evidence 
for the role of somatic, or physiological, arousal comes from studies demonstrating higher 
metabolic  rate  and  reduced  heart-rate  variability  in  patients  with  primary  insomnia 
compared  with  good  sleeper  controls.
26,27   Increased  cortical  arousal  has  been 
demonstrated by studies demonstrating increased nREM high frequency EEG in patients 
with insomnia and investigations using functional neuroimaging techniques demonstrating 
greater global cerebral glucose metabolism.
28,29  
 
As opposed to hyperarousal, the psychobiological inhibition model of insomnia proposes 
that insomnia occurs in association with the failure to inhibit wakefulness.
30  Cognitive 
phenomena thought to be implicated in this difficulty include an attentional bias towards 
automatic processes which in turn prevents perceptual and behavioural disengagement, and 
sleep effort.  Evidence in support of this model come from studies indicating that people 
with  psychophysiological  insomnia  have  been  shown  to  exhibit  heightened  levels  of 
attentional bias and effortful preoccupation with sleep.
31, 32        
 
Psychological  interventions,  predominantly  taking  a  Cognitive  Behavioural  Therapy 
(CBT)  approach  have  used  techniques  based  on  the  theoretical  underpinnings  outlined 
above such as stimulus control, cognitive restructuring and imagery and relaxation.
33  A 
recent  review  of  the  evidence-base  for  psychological  and  behavioural  interventions   49 
reported that CBT produced reliable and sustained changes on several sleep parameters.
34  
A  meta-analysis  by  Riemann  &  Perlis  concurs  that  psychological  therapy  produces 
improvements  comparable  to  pharmacotherapy  during  the  treatment  period  with  the 
advantage of beneficial long-term effects.
35    
  
Considering  insomnia  as  a  psychophysiological  sleep  disorder,  in  which  cognitive  and 
behavioural factors play key roles, has lead to much progress in the understanding of its 
aetiology  and  treatment.    The  question  arises  as  to  whether  the  study  of  nREM 
parasomnias, also a psychophysiological disorder could be approached in a comparable 
manner.  Ohayon et al reported that their night terror group had significantly higher rates of 
psychophysiological  insomnia  than  their  group  with  no  parasomnia  (6.4%  vs  1.9%).  
Although there was no such higher rate in the sleepwalking group (2.0%), this indicates 
some  comorbidity  between  the  two  sleep  disorders  and  perhaps  some  overlapping  but 
distinct psychological mechanisms.
6   
 
Aims and hypotheses 
Aims 
This study aimed to take into account what the literature offers thus far with regards to 
people  who  experience  nREM  parasomnias  in  conjunction  with  the  more  established 
research base on insomnia and its associations with psychological factors.  As such, an 
attempt is made to profile nREM parasomnias in relation to a number of the psychological 
variables introduced above, namely emotional inhibition, worry, rumination and arousal.  
A further objective was to explore any specificity of these variables to people experiencing 
nREM  parasomnias  relative  to  another  sleep  disordered  group.      A  controlled  cross-
sectional  study  was  conducted  with  the  index  group  of  interest  being  the  nREM 
parasomnia group, a parallel sleep disorder group of people with insomnia and a control 
group of good sleepers. 
 
 Hypotheses 
The present study aimed to test the following hypotheses:  
  It was first hypothesised that, confirming findings from previous research, people 
with insomnia will have levels of a) Emotional inhibition, b) Worry, c) Rumination 
and d) Arousal that are elevated relative to good sleepers.   50 
  It was secondly hypothesised that, relative to good sleepers, the group experiencing 
nREM  parasomnia,  also  a  psychophysiological  disorder,  will  also  have  higher 
levels of: a) Emotional inhibition, b) Worry, c) Rumination and d) Arousal. 
 
Research questions 
It  was  not  clear,  however,  whether  there  would  be  any  differences  on  these  variables 
between the nREM parasomnia and insomnia group and in what direction this may be.  
Therefore several research questions with regards to these two clinical groups emerged:    
  Are there differences between the insomnia and nREM parasomnia group in the 
nature  or  degree  of  a)  Emotional  inhibition,  b)  Worry,  c)  Rumination  and  d) 
Arousal? 
 
 
Methods 
 
Participants 
Participants were aged 18 and over, reporting English as their first language.  Allocation to 
the nREM parasomnia group and insomnia group was based on meeting criteria outlined in 
the (ICSD2)  for nREM parasomnia  and insomnia respectively.
8 (see  Appendix 2:3  for 
criteria).  To ensure that participants within the nREM parasomnia group could be defined 
as  “currently”  experiencing  these  phenomena,  participants  were  also  required  to  have 
experienced an episode within the past six months.  Criteria for admission to the control 
group  were  not  meeting  criteria  for  insomnia  or  nREM  parasomnia  and  reporting 
satisfaction with the amount of sleep obtained.  
 
Conditions for exclusion included: Symptomatic evidence of another sleep disorder (e.g. 
sleep  apnoea  or  periodic  limb  movement  disorder);  Sleep  disturbance  attributed  to  a 
psychiatric/medical  condition  or  neurological  disorder;  significant  drug  or  alcohol  use. 
People meeting criteria for both nREM parasomnia and insomnia were excluded from the 
study. 
Approximately 300 people were spoken to about the study and a structured interview was 
administered to 239 of these people with 33 people being excluded at this stage for the 
following reasons: 11 people did not meet inclusion criteria for any of the group (i.e. did 
not experience insomnia or nREM parasomnia but did not report satisfaction with sleep); 
12  reported  symptoms  of  another  sleep  disorder;  2  people  met  criteria  for  nREM   51 
parasomnia  and  insomnia;  2  people  did  not  speak  English  as  their  first  language;  3 
experienced REM parasomnia (e.g. REM sleep behaviour disorder) as opposed to nREM 
parasomnia; 2 were deemed to be experiencing mental health difficulties which would 
impact on their ability to participate in the study; 1 person experienced insomnia due to 
being pregnant and 2 people had not encountered their nREM parasomnias within the last 6 
months.  Of the remaining 206 people who were given the questionnaire either in person, 
via email or sent in the post, 44 did not complete this.  Thus, 162 volunteers participated 
fully in the study.  Demographic information was collected with regards to participants‟ 
age, gender and postal address.       
 
Participant recruitment 
Participants were recruited via the University of Glasgow Sleep Centre‟s (UGSC) ongoing 
operational procedures.  As such, advertisements were placed on the UGSC website and 
posters displayed in GP surgeries and on University of Glasgow premises.  Participants 
who had not been suitable for previous studies at the UGSC but had agreed to be contacted 
for  future  studies  were  also  identified.    Some  participants  were  sourced  through  the 
parasomnia clinic at the UGSC.  Three sleep professionals working clinically with people 
with nREM parasomnia were contacted about the study and agreed to inform their clients 
about the study and distribute participant information sheets.       
 
The study was publicised via articles in national newspapers, social networking posts by 
the  Mental  Health  Foundation  (www.facebook.com/mentalhealthfoundation)  and 
advertising at the Glasgow Science Centre.  Members of the public who had taken part in 
the Great British Sleep Survey (http://www.sleepio.com/survey/), indicating a presence of 
a nREM parasomnia, were informed about the study and invited to contact the researcher if 
they were interested in participating.   
 
This  study  was  developed  as  part  of  a  larger  programme  of  research  and  suitable 
participants recruited into a parallel study investigating stress reactivity in people with 
nREM parasomnia, insomnia and good sleepers were offered the opportunity to take part in 
this study and vice versa.  Additional recruitment was achieved via social connections and 
colleagues of the researcher.  
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Research procedure 
People interested in participating in the study were invited to contact the UGSC by e-mail, 
telephone or face-to-face.  Potential participants were screened using the UGSC standard 
screening interview administered to all volunteers intending to be involved in research at 
the UGSC, with additional screening items in relation to criteria for nREM parasomnia and 
specific health and demographic questions (Appendix 2.4).  If deemed suitable, they were 
provided  with  a  participant  information  sheet  (Appendix  2.5)  and  a  consent  form 
(Appendix 2.6).  Depending on their preference, those who consented to taking part were 
then emailed a link to the online version (see Appendix 2.7 for image of site homepage) of 
the questionnaire or provided with the paper set of questionnaires either by post or in 
person. 
 
Study design 
The study consisted of a between-groups cross-sectional design with three groups: Adults 
with primary insomnia, nREM parasomnia (nREMp) and good sleepers (GS).  The primary 
independent variables in relation to the hypothesis outlined were participants‟ scores on 
self-report measures of emotional inhibition, rumination, worry and arousal.  Group was 
the main independent variable.   
 
Justification of sample size/Power calculation 
No previous studies investigating any of the constructs of arousal, emotional inhibition, 
worry and rumination in relation to a nREM parasomnia population could be identified on 
which to base an estimated effect size. However studies investigating insomnia groups 
compared to controls have yielded large effect sizes.  For example, using data from a study 
by Harvey & Greenall, an effect size of d=1.07 was found between an insomnia group and 
good  sleepers  on  measures  of  worry,  which  would  correspond  to  a  large  effect  size 
according to Cohen‟s effect size conventions.
23,36   In answering its final research question, 
the present study investigated possible differences between two clinical populations and it 
was deemed likely that sufficient power would be required to detect a more conservative, 
medium effect size.   A priori sample size calculations were conducted using the G*Power 
3 software program for an independent samples t-test (two-tailed).
37  With a significance 
level  set  at  0.05,  a  standard  power  of  0.8  and  a  medium  effect  size  of  d=0.5,  it  was 
calculated that a sample size of 64 would be required in each group.  The researcher aimed 
to recruit up to 100 participants per group and it was expected that obtaining this sample 
size  would  be  sufficient  to  detect  any  significant  differences  between  the  two  clinical   53 
groups,  in  addition  to  differences  between  the  clinical  and  control  groups.    It  was 
anticipated that applying strict criteria for inclusion into the study and attempting to match 
the groups with regards to age and gender would also enhance the power of the study in 
detecting any existing effects
II.  
 
Measures 
 
Demographic, screening, sleep and clinical measures  
Screening interview  
Participants  were  screened  administering  the  generic  UGSC  intake  interview  with 
additional study specific questions.  Information gathered included age, postal address, 
weekly alcohol intake, drug use and medical history. (Appendix 2.4)  
 
Participants  were  asked  questions  based  on  criteria  outlined  in  the  ICSD-2  for  nREM 
parasomnia and insomnia.  Those meeting criteria for either category of disorders were 
also asked questions with regards to the history and frequency of their sleep phenomena.     
 
To ensure the absence of another sleep disorder, the screening interview consists of a brief 
algorithm  based  on  criteria  for  narcolepsy,  sleep  breathing  disorder,  restless  leg 
syndrome/periodic  limb  movement  syndrome,  circadian  rhythm  sleep  disorder  and 
parasomnia (including REM parasomnias).
38    
 
Sleep  
The Pittsburgh Sleep Quality Index (PSQI) was utilised to provide a quantitative measure 
of sleep disturbance in addition to the above interview.
39  This self-report questionnaire 
measures estimated sleep quality and disturbance over 1 month.  A global PSQI score 
of >5 has a reported sensitivity of 89.6% and specificity of 86.5% in distinguishing those 
with clinically significant sleep disturbance from those without.  The PSQI has been shown 
to have a satisfactory level of internal consistency (α = 0.83).  
 
The Sleep Condition Indicator (SCI) was also employed.
40  The SCI is an unpublished self-
report  measure  based  upon  proposed  DSM-5  sleep  disorder  criteria 
(http://www.dsm5.org/ProposedRevision/Pages/Sleep-WakeDisorders.aspx)  which  has 
been developed at the UGSC and for which data has thus far been collected on 12,000 
                                                 
II In practice matching was conducted post-hoc, as outlined in the sample characteristics section of the 
results, because all attempts were made to maximise attainment of the target sample size.    54 
people.  Participants are asked to report on the pattern of their sleep over the past month in 
addition to the quality of their sleep, the impact any poor sleep has had on their life and the 
level of concern they have had about their sleep.  Questions about the history of sleep 
problems are also included.  The SCI has demonstrated good internal consistency (α = 
0.89).
40 
 
An Impact of Poor Sleep Assessment was also used to confirm group allocation and covers 
six areas outlined in the DSM-5 proposed criteria for insomnia regarding the impact of 
sleep on daytime functioning 
41Specifically questions are asked in relation to mood, energy, 
relationships, daytime sleepiness, concentration and functioning at work. 
 
 
Clinical 
The  Depression  Anxiety  Stress  Scales  (21  items)  (DASS21)  is  a  21-item  self-report 
measure of depression, anxiety and stress and was selected because it includes a specific 
stress scale and takes a dimensional view of DAS symptoms
42; appropriate because this 
study was designed to exclude people with clinical disorders.  Internal consistency for the 
scales are satisfactory with α=0.93 for the total scale, and α=0.88, α=0.82 and α=0.90 for 
the depression, anxiety and stress scales respectively.   
 
Outcome measures  
Emotional Inhibition 
Emotion Inhibition was assessed using the Emotion Inhibition Subscale of the Emotion 
Control  Questionnaire  (ECQ-EI).
43  Participants  were  asked  to  rate  14  statements  and 
situations as generally “true” or “false”.  E.g. “people find it difficult to tell if I‟m excited 
about something or not”.  The ECQ-EI has been shown to have good internal consistency 
(α=0.77) and test-retest reliability (r=0.71).    
 
The Acceptance & Action Questionnaire – II (AAQ-II) is a 7-item self-report questionnaire 
that measures psychological inflexibility and experiential avoidance.
44  Developed within 
the context of Acceptance and Commitment Therapy, this relates to an attempt to alter the 
form, frequency or situational sensitivity of difficult private events (i.e. thoughts, feelings 
and physiological sensations).  E.g. “I worry about not being able to control my worries 
and feelings”.  This questionnaire also has good psychometric properties (α=0.84). 
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Rumination and Worry  
Rumination  was  assessed  using  The  Rehearsal  Subscale  of  the  Emotion  Control 
Questionnaire (ECQ-R).   Participants are asked to rate 14 statements and situations as 
generally “true” or “false”. E.g. “I get worked up just thinking about things that have upset 
me in the past”, “I remember things that upset me or make me angry for a long time 
afterward”.  The ECQ-R has been shown to have high internal consistency (α=0.86) and 
test re-test reliability (r=0.80).
43  
 
Worry was measured using the Penn State Worry Questionnaire (PSWQ), a 16-item self-
report  instrument  which  measures  the  trait  of  worry.
45  Items  include  “I  am  always 
worrying about something” and “I have been a worrier all my life”.  The PSWQ has strong 
internal consistency (α=0.95) and test re-test reliability (r=0.93).   
 
Arousability 
Arousability was measured using the Arousal Predisposition Scale (APS).
46  The APS is a 
12-item self-report measure of arousability demonstrated to have a split-half reliability of 
0.83 and to predict individual differences in physiological arousal.
46  Examples of items 
are “I find that my heart keeps beating fast for a while after I have been “stirred up”” and 
“I get excited easily”. 
 
The Sleep Arousal Scale  (SAS) was  also  utilised.
47  The SAS  is  a 16-item  self-report 
measure  which  comprises  both  cognitive  and  somatic  manifestations  of  arousal.  
Participants are asked to rate how intensely they experience symptoms as they attempt to 
fall asleep or return to sleep.  Items include “Worry about falling asleep” (cognitive) and 
“Heart  racing,  pounding  or  beating  irregularly”  (somatic).    Internal  consistency  for 
cognitive (8 items) and somatic (8 items) are good (α=0.76 and α=0.81 respectively). (see 
Appendix 2.8 for all measures).      
 
Approach to data analysis 
Data were first  summarised to  provide descriptive statistics.   Preliminary  analysis was 
conducted to  check whether the three  groups  differed  with  respect  to age,  gender  and 
socioeconomic status.  Before conducting formal analysis, all variables were inspected to 
see if assumptions for parametric analysis were met.  Normality of each distribution was 
checked using graphical and numerical methods with reference to skewness and kurtosis.  
Homogeneity of variance was assessed using Levene‟s test for equality of variances.  Data 
not  meeting  these  assumptions  were  transformed  using  square  root  or  logarithmic   56 
transformations
48,  and  where  data  could  not  be  rectified,  appropriate,  equivalent  non 
parametric tests were employed.             
 
To test the main hypotheses, group differences with regard to the dependent variables were 
analysed using one way analysis of variance (ANOVA).  Where significant effects were 
found,  post  hoc  Bonferroni  tests  were  used  to  identify  associated  between  group 
differences.  Subsequently,  Bonferroni  corrections  were applied  conservatively to  see if 
effects remained significant upon controlling for multiple comparisons.  To investigate the 
impact of age as a covariate, analyses of covariance (ANCOVA) was  also considered.  
However in each case, the main effect remained significant and so original ANOVA results 
are  referred  to  throughout  the  text  (see  Appendix  2.9  for  all  post-hoc  analysis  and 
ANCOVA results).    
 
Internal  consistency  was  ascertained  for  each  dependent  measure  on  the  whole  study 
sample,  calculating  Cronbach‟s  alpha  coefficient  (α)  for  continuous  data  and  Kuder-
Richardson formula 20 (KR20) for dichotomous data.         
  
Relationships  between  the  variables  were  finally  explored  using  correlations.    To 
investigate correlations between all dependent measures and the DASS subscales it was 
acknowledged that a substantial proportion of the data were not normally distributed and 
therefore  a  Spearman‟s  rank  order  correlation  coefficient  was  used.    For  subsequent 
specific correlations where data were normally distributed, the more powerful Pearson‟s 
product moment correlation was calculated.      
 
Analyses  were  conducted  using  Statistical  Package  for  Social  Sciences  (PASW  18) 
software package.  Due to the exploratory nature of this study, tests were two-tailed with 
significance set at criteria p < 0.05 unless otherwise specified.  
 
 
Ethical approval 
NHS ethical approval and R&D approval was obtained from the Greater Glasgow & Clyde 
West of Scotland Research Ethics Service (See Appendix 2.10 for copy of approval letter). 
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Results 
 
Sample characteristics 
162 eligible participants completed the study.  A disproportionate number of participants in 
the Good Sleeper group completed the study and therefore 12 of these were withdrawn 
from analysis to create more even sample sizes across groups.  It is important to highlight 
that this was process was conducted independent of scores on the outcome variables of the 
study.  In selecting data to remove, attempts were made to improve matching to the index 
sample of participants with nREM parasomnias with regards to gender and maintain close 
matching  in  age  to  this  group,  thus  reducing  unexplained  variance.    For  example,  by 
removing  6  females  and  6  males  from  the  Good  Sleeper  group,  the  ratio  of  males  to 
females in this group became closer to that of the nREM parasomnia group.  Participant‟s 
score on the PSQI was also considered in selecting participants for withdrawal, with 8 
participant‟s data removed taking into account their score of > 5 on this measure (see 
Appendix  2.11  for  specific  details  concerning  participants  removed).    A  final  148 
participants were included for analysis and, based on the diagnostic and inclusion criteria 
applied, 50 were categorised as  Good Sleepers (GS), 50 had  Insomnia  and 48 had an 
nREM parasomnia (nREMp).  
 
Table  2.1  provides  demographic  details  of  the  participants.  The  mean  age  across  all 
participants was 38.9 years (SD= 14.14) with a total of 101 females and 47 males.  With 
regards to group differences in demographic data, ANOVA  and Bonferroni‟s post hoc test 
revealed that the Insomnia group was significantly older than both the nREMp (p<0.001) 
and  GS  groups  (p<  0.001).    Therefore  subsequent  hypothesis  testing  was  performed 
initially without a covariate (ANOVA) and repeated with age as a covariate (ANCOVA).  
There were no gender differences between groups (X
2 = 2.650, p = 0.266).   
 
A total of 122 (82.43%) participants were based in Scotland, 22 lived in England (14.86%), 
2 (1.35%) were currently residing in Australia, 1 person (0.68 %) lived in Northern Ireland 
and  1  (0.68%)  in  Belgium
III.  An indicator of socioeconomic status based on postcode was derived for participants 
living in Scotland and the groups did not differ significantly according to this index (X
2 = 
                                                 
IIIWith the use of web-based recruitment it was not easily possible to restrict the sample to the UK.  
Participants residing outside the UK had contacted the UGSC upon viewing the centre‟s website or had 
been living in the UK when they initially found out about the study and subsequently moved abroad.  No 
active attempts to recruit overseas were made.   58 
4.850, p=0.09) (see Appendix 2.12).
IV  The mean number of units of alcohol consumed by 
the overall sample was 6.28 per week and intake did not differ significantly between 
groups [F(2,141) = 0.039, p=0.902].  Regular recreational drug use was not reported by 
any of the participants.   
 
All participants in the nREM parasomnia group had experienced either a night terror or 
sleepwalking in the past 6 months.  With regards to subtypes, 14 (29.2%) experienced 
sleepwalking,  24  (50  %)  experienced  night  terrors  and  10  (20.8%)  experienced  both 
phenomena.    Figure  2.1  presents  information  on  the  frequency  with  which  people 
experienced their nREM parasomnia in the past 6 months.   Although several participants 
stated that this was variable, estimates ranged from at least once per night to twice in total 
within this time frame.  Participants were also asked the age at which they first experienced 
their nREM parasomnia, the details of which are presented in Figure 2.2.   
 
 
Figure 2.1  Frequency of nREM parasomnia episodes in past 6 months 
 
 
 
 
 
                                                 
IV It was not possible to convert English to Scottish deprivation scores.  An index based on Scottish data, 
being the largest sub-sample, therefore serve as a proxy to an indication of socioeconomic status of the 
study sample   59 
Figure 2.2 Age experienced first nREM parasomnia episode 
 
 
 
 
 
 
 
 
 
 
 
 
 
In the Insomnia group, the average duration of sleep difficulties was 15.2 years (range 
0.1-50.9).  Of the 25 participants reporting to have had a problem for at least 11 years, 
10 reported that they did not “sleep okay as a child”, suggesting a more idiopathic form 
of primary insomnia.     
 
Sleep characteristics across groups  
The  mean  scores  and  standard  deviations  for  each  of  the  sleep  measures  are  also 
presented in Table 2.1.  As expected, those in the GS group scored significantly lower 
than both the nREMp and Insomnia group in the PSQI, the SCI and the Impact of poor 
sleep questionnaire, confirming that they are good sleepers.  With regards to the two 
sleep disordered groups, those with insomnia scored significantly higher on the PSQI 
and on the SCI but there were no such significant differences in the Impact of poor sleep 
questionnaire.      
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Table 2.1 Demographic, sleep and clinical characteristics 
  
Measure  GS  nREM p  Insomnia   F(2,145)  P  Post-hoc 
(N = 50)  (N= 48)  (N= 50 )  X
2(2)     
Mean (SD)  Mean (SD)  Mean (SD)      
  
Age (years)  36.54 
(11.6) 
32.37 
(11.6)  47.56(14.5)  18.885  <0.001  I>nREMp=GS 
             
Alcohol   6.47 (5.84)  6.15(6.03)  6.21 (6.14)  0.039  0.902   
           
 
Gender:  N (%)  N(%)  N(%)     
Male  15 (30)  12 (25)  20 (40)  2.65  0.266 
Female  35 (70)  36 (75)  30 (60)     
           
           
Sleep data:   Mean 
(SD)  Mean (SD)  Mean (SD)       
             
PSQI  2.80 (1.7)  7.21 (4.1)  12.02 (3.5)  113.912  <0.001  GS<nREMp<I 
             
SCI 
a   2.82 (5.7)  15.79 (7.1)  22.26 (5.7)  101.22  <0.001  GS<nREMp<I 
             
Impact of 
poor sleep 
2.06 (6.6)  11.29 (7.1)  13.32 (6.6)  77.805  <0.001  GS<nREMp=I 
             
Clinical 
data:             
             
DASS21
a:             
Depression  1.24 (2.3)  8.17 (9.8)  9.32 (8.7)  42.165  <0.001  GS<nREMp=I 
             
Anxiety  0.94 (1.4)  7.17 (6.9)  6.68 (6.4)  55.299  <0.001  GS<nREMp=I 
             
Stress   4.76 (5.70)  12.50 (8.7)  15.04 (7.3)  47.871  <0.001  GS<nREMp=I 
             
a Kruskal-Wallis Test and Mann-Whitney Tests for post-hoc pairwise comparisons   
 
GS = Good Sleepers, NREMp = NREM parasomnia, I = Insomnia, PSQI = Pittsburgh 
Sleep Quality Index, SCI = Sleep Condition Indicator  
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Clinical characteristics across groups 
Table 2.1 also displays the clinical characteristics of each group as measured by the 
DASS21.  The GS group scored significantly lower on all three scales compared with 
both the Insomnia and nREMp group.  There were no significant differences between 
scores in the two sleep disordered groups on any of the scales.  It should be highlighted 
that  the  mean  scores  for  each  group  fall  within  the  normal  and  mild  level  severity 
categories of each scale of the DASS.
49  Therefore although significant differences are 
evident between groups, these lie at the lower (likely subclinical) end of the scale and as 
such neither depression, anxiety or stress was considered as a covariate in subsequent 
testing of the main hypotheses (see Appendix 2.13) for a frequency count of participants 
in each severity category for the three DASS scales across groups).         
 
 
Hypothesis testing 
The descriptive statistics for each measure used in hypothesis testing are displayed in 
Table 2.2.  The nREM parasomnia and Insomnia groups were both hypothesised to have 
higher levels on all variables compared with the good sleepers with differences between 
the two sleep disordered groups remaining an open research question.  The results in 
relation to these hypotheses are presented separately for each variable below.   
 
Emotional Inhibition  
The mean scores and standard deviations on the Emotional Inhibition subscale of the 
ECQ are displayed for each group in Table 2.2 and presented graphically in Figure 2.3.  
It can be seen that, as hypothesised, both sleep disorder groups scored higher than the 
good sleepers on this scale.  A one-way ANOVA revealed a significant main effect 
between groups [F(2,145) = 7.508, p < 0.001].  Bonferroni‟s post-hoc analysis was 
conducted  to  clarify  these  differences.    Those  within  the  nREMp  group  scored 
significantly higher than the GS group (P=0.001).  The Insomnia group also scored 
significantly higher than the GS group (P=0.01).  With regards to the research question 
concerning  comparisons  between  the  Insomnia  and  nREMp  group,  no  significant 
differences were found (p=1).  The internal consistency of the Emotional Inhibition 
subscale was found to be high (KR20 = 0.81). 
 
Table 2.2 and Figure 2.3 also display the mean scores and standard deviations on the 
AAQ-II.    A  one-way  analysis  of  ranks  (Kruskal-Wallis)  was  used  to  investigate 
differences between the three groups on this variable.  A significant group difference 
was  found  (X
2  =  13.119,  P  <  0.001).    Subsequent  pair-wise  analysis  using  Mann-  62 
Whitney tests revealed that the Insomnia group scored significantly higher than the GS 
(p<0.001).    The  nREMp  scores  were  also  significantly  higher  than  the  GS  group 
(p<0.001), confirming the first two hypotheses.  Again, no such differences were found 
between the two  clinical  groups (p= 0.94).  Internal  consistency  of the  AAQ-II  was 
demonstrated to be high (α = 0.81). 
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Table 2.2 – Outcome analysis  
             
Measure  GS  nREMp  Insomnia  F(2,145)     P  Post – hoc 
N = 50  N = 48  N = 50  X
2 (2)   
Mean 
(SD) 
Mean 
(SD) 
Mean 
(SD) 
     
Emotional 
inhibition             
             
             
ECQ-EI   4.60(1.8)  5.92 (2.0)  5.70 (1.7)  7.508  0.001  nREMp=I>GS 
             
AAQ-II
 a  12.48(4.2)           19.31 (9.9)  19.24 (9.2)  13.119  0.001  nREMp=I>GS 
             
Rumination & 
Worry              
             
ECQ-R   4.42 (2.7)  7.23 (3.1)  5.86 (3.4)  10.053  <0.001  nREMp>GS 
             
             
             
PSWQ
b  37.24 
(10.3) 
47.44 
(12.1) 
48.4 
(14.4)  12.158  <0.001  nREMp=I>GS 
             
Arousability             
             
APS   28.66 (6.7)  34.25 (7.5)  32.42 (8.2)  7.08  0.001  nREMp=I>GS 
             
SAS cognitive
a  13.4 (4.5)  18.73 (6.0)  25.28 (5.8)  70.201  <0.001  I>nREMp>GS 
SAS somatic
a  8.58 (1.0)  12.50 (4.5)  13.48 (4.2)  60.694  <0.001  nREMp=I>GS 
                    
             
a Kruskal-Wallis Test with Mann-Whitney Tests for post-hoc pairwise comparisons   
 
b Data transformed using logarithmic transformation 
 
GS = Good Sleepers, nREMp = nREM parasomnia, I = Insomnia  
ECQ-EI = Emotional Control Questionnaire-Emotional Inhibition Subscale; AAQ-II = 
Acceptance  &  Action  Questionnaire  II;  ECQ-R  =  Emotional  Control  Questionnaire 
Rehearsal  Subscale;  PSWQ  =  Penn  State  Worry  Questionnaire;  APS  =  Arousal 
Predisposition Scale; SAS cognitive = Sleep Arousal Scale cognitive subscale; SAS = 
Sleep Arousal Scale somatic scale 
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Figure 2.3. Mean scores and standard deviations for (a) ECQ-EI and (b) AAQ-II 
(a) 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Rumination and worry 
Rumination was measured by the Rehearsal subscale of the ECQ and mean scores and 
standard deviations are presented for each group in Table 2.2 and Figure 2.4.   Higher 
scores are evident in the 2 clinical groups.  A one-way ANOVA revealed a significant 
main effect between groups [F(2,145) = 10.053, p < 0.001].  Supporting the hypothesis 
that  higher  levels  of  rumination  would  be  evident  in  those  experiencing  nREM 
parasomnia  compared  to  good  sleepers,  a  Bonferroni‟s  post-hoc  analysis  revealed  a 
significant  difference between these two  groups (p < 0.001).   No other significant 
(b)   65 
group  differences  were  uncovered.    However,  the  difference  in  means  between  the 
Insomnia  and  GS  group  represented  a  small  to  medium  effect  size  of  d=0.47.      A 
retrospective power analysis was calculated to determine what sample size would be 
required  in  each  group  to  detect  a  meaningful  difference  should  it  exist.    With  a 
significance level set at an α level of 0.05, a standard power of 0.8 (one-tailed), the 
number  required  was  calculated  to  be  57.    Appendix  2.14  provides  a  tabular 
presentation  of  effect  sizes  and  p-values  revealed  for  all  pair-wise  comparisons 
indicating  at  what  magnitude  of  effect  significance  is  demonstrated.      Satisfactory 
internal consistency was demonstrated for the Rehearsal subscale (KR20 = 0.78).   
 
Mean scores and standard deviations are presented in Table 2.2 and Figure 2.4 for all 
three groups on the PSWQ.  A one-way ANOVA found a significant group effect [F 
(2,145) = 12.158, p<0.001].  It was hypothesised that both the Insomnia and nREMp 
group would score higher than the GS group and this was confirmed with Bonferroni‟s 
tests  (p  <  0.001  and  p<  0.001  respectively).    In  relation  to  the  research  question 
concerning  the  two  sleep-disorder  groups,  no  significant  differences  were  revealed 
(p=1).  Internal consistency of the PSWQ was high (α = 0.93).    
 
 
Figure 2.4  Mean scores and standard deviations for (a) ECQ-R and (b) PSWQ 
 
(a) 
   
 
   66 
 
(b) 
   
Arousal  
It was hypothesised that people in the insomnia and nREM parasomnia groups would 
report higher levels of arousal than good sleepers.  The question was also raised as to 
whether there would be any differences between the two sleep disordered groups on 
these  measures.  Table  2.2  and  Figure  2.5  display  the  mean  scores  and  standard 
deviations for the APS for each group.   A one-way ANOVA resulted in a significant 
group effect [F(2,145) = 7.080, p<0.001].  A post-hoc Bonferroni‟s test revealed that 
both the Insomnia and nREMp group scored higher than the GS group (p=0.04 and 
p=0.001  respectively).    However,  applying  Bonferroni‟s  corrections,  increasing  the 
significance level to a more conservative p<0.017 the difference between the GS and 
Insomnia  group  no  longer  met  significance.  No  significant  differences  were  found 
between the two sleep disordered groups (p=0.69).  A high internal consistency of the 
APS was demonstrated (α = 0.84).      
  
Mean scores and standard deviations for the cognitive and somatic subscales of the SAS 
are also displayed in Table 2.2 and Figure 2.5.  The highest scores were found in the 
Insomnia group, this being particularly evident in the cognitive subscale.  Considering 
the cognitive subscale initially, a Kruskal-Wallis test indicated a significant group effect 
(X
2 = 70.201, p< 0.001).  Pairwise analysis using Mann-Whitney tests showed that the 
Insomnia group were significantly more cognitively aroused than the GS (p <0.001), as 
were  the  nREMp  group  (p<0.001).    Those  in  the  Insomnia  group  also  scored   67 
significantly higher than the nREMp group (p < 0.001) on this measure.  A significant 
group effect was also found on the somatic subscale (X
2 = 60.694, p < 0.001) with both 
the Insomnia and nREMp group scoring significantly higher on this measure than the 
good sleepers (p < 0.001 and p < 0.001 respectively).  Although scores were higher on 
this subscale in the Insomnia group compared with the nREMp group, this difference 
was not found to be significant (p = 0.118).   Internal consistency of both the cognitive 
and somatic subscales were good (α = 0.89 and α = 0.78 respectively). 
  
Figure 2.5 Mean scores and standard deviations for (a) APS, (b) SAS cognitive & 
(c) SAS somatic  
(a) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(b)   68 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Associations between dependent variables and DASS subscales  
Correlations were investigated between the dependent variable measures and each of the 
DASS subscales (see Appendix 2.15 for correlation matrix).  Significant correlations 
(P<0.001)  were  found  between  all  measures  indicating  an  association  and  potential 
overlap  between  some  of  the  constructs  being  measured.    However,  values  for 
Spearman‟s  rank  order  correlation  coefficient  were  all  within  the  low  or  moderate 
correlation ranges indicating that distinct psychological constructs are being measured.  
Interestingly, the lowest correlation was between the AAQ-II and ECQ-II scale (rs = 
0.303)  whereby  variability  of  scores  on  one  questionnaire  is  accounted  for  by  only 
9.18% of variability in the other.  The highest correlation was between the APS and the 
PSWQ (rs = 0.668) where approximately 45% of the variance of the former is explained 
by the latter.    
  
Associations between the PSQI and ECQ-EI   
Correlations between sleep quality and emotional inhibition as measured by the PSQI 
and the ECQ-EI were explored.  In line with the differences in scores on the ECQ-EI 
between  the  sleep  disordered  groups  and  the  good  sleepers,  PSQI  was  found  to  be 
significantly positively correlated with ECQ-EI (r = 0.240, p<0.005).   
 
In  consideration  of  the  aforementioned  differences  between  groups  on  each  of  the 
DASS subscales, the influence of these subscales on the relationship between the ECQ-
EI and the PSQI was investigated by conducting partial correlations, controlling for the 
effects of each subscale individually.  Indeed, the correlation between the PSQI and 
(c) 
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ECQ-EI did not hold when the Depression, Anxiety and Stress subscales of the DASS 
were controlled for (r=0.075, p=0.18), indicating that the relationship could be due to 
this third factor.    
 
 
Discussion 
 
Little  attention  has  been  paid  to  psychological  processes  associated  with  nREM 
parasomnias, although stress is commonly associated with their expression, and there 
appears  to  be  a  higher  prevalence  of  mood  disorder,  compared  to  healthy  subjects.  
Expert  opinion  has  also  suggested  that  people  with  nREM  parasomnias  may  be 
„emotionally inhibited‟.  By contrast, there is a relative wealth of research on insomnia, 
another sleep disorder of a psychophysiological nature which can be potentiated by 
stress.  Could it be that factors contributing to the development and maintenance of 
insomnia might also be implicated in nREM parasomnias?  The present study aimed to 
profile nREM parasomnias on a number of psychological variables, drawn from the 
limited  literature  on  this  particular  disorder,  as  well  as  from  the  more  established 
insomnia evidence base.  The main findings are discussed, followed by a consideration 
of the strengths and limitations of the study and its clinical and research implications.    
 
Insomnia: emotional inhibition, worry, rumination and arousal 
As hypothesised, the insomnia group reported higher levels on measures of emotional 
inhibition, worry and trait-like arousability in addition to cognitive and somatic pre-
sleep  arousal.    The  expected  outcome  of  increased  rumination,  however  was  not 
established.   
 
The  elevated  levels  of  emotional  inhibition,  measured  by  the  emotional  inhibition 
subscale of the ECQ, compared with good sleepers, are concurrent with Vela-Bueno et 
al‟s finding of associations between emotional inhibition (using the same scale) and 
sleep quality.  It could be understood in the context of theories such as those proposed 
by Pennebaker who argues that emotional inhibition results in an increase in stress and 
intrusive, ruminative thoughts.
50  It could be that it is its association with these factors 
that leads to an increased vulnerability to insomnia in the way that it has been proposed 
for other psychological difficulties.  The finding that this group scored higher on the 
AAQ-II, which specifically measures experiential avoidance, is in line with arguments 
for the use of mindfulness based techniques in addition to traditional CBT strategies in 
treating  insomnia.    Increased  experiential  avoidance  could  involve  controlled 
information processing strategies contributing to the inhibition of de-arousal proposed   70 
in Espie‟s model of insomnia.
51 This may be amenable to change through techniques 
endorsed  in  mindfulness  approaches  such  as  encouraging  the  acceptance  of 
spontaneously occurring physiological and mental processes.
52  There has been little 
prior use of this particular measure in insomnia populations with the exception of a 
study by McCracken et al in which associations were found with measures of sleep 
quality in chronic pain patients with insomnia.
53   
 
Confirming findings from previous research, the higher levels of self-reported worry in 
the insomnia group, provide increased support for Harvey‟s aforementioned cognitive 
model which emphasises its role in insomnia.
23   No such significant difference was 
found on the measure of rumination used, indicating that this related concept is perhaps 
not  as  predominant  in  insomnia.    However,  retrospective  power  analysis  showed  a 
sample size of 57 would be required to detect a meaningful difference should it exist 
and it may be that the study was underpowered in this respect.   
 
Replicating findings of previous research into arousability, it was also found that those 
with  insomnia  reported  more  cognitive  and  somatic  arousal  compared  with  good 
sleepers.  With  regards  to  the  more  trait  like  arousal  predisposition  scale,  applying 
Bonferroni‟s  corrections,  increasing  the  significance  level  to  a  more  conservative 
P<0.017, meant an initial significant difference on this measure was no longer present.  
It  is  recognised,  however,  that  a  trade-off  exists  between  that  of  controlling  the 
familywise error rate but increasing the risk of a type-II error and therefore the initial 
significance achieved should be not be discarded as uninformative. 
 
nREM parasomnia: emotional inhibition, worry, rumination and arousal 
With  regards  to  hypotheses  concerning  the  primary  index  group  of  interest,  the 
participants experiencing nREM parasomnias reported significantly higher levels on all 
measurements of emotional inhibition, worry, rumination and arousability. 
 
The  finding  of  higher  levels  of  emotional  inhibition  relative  to  good  sleepers  is 
congruent with previous research pointing to this characteristic in people with nREM 
parasomnias.  It also provides empirical support to anecdotal reports from clinicians 
working  therapeutically  with  this  group  (Espie,  personal  communication).    Such 
professionals have described clients with nREM parasomnias to have a tendency to 
cope well with stress at a surface level, appearing calm and in control but, that through 
therapeutic exploration, an underlying emotional vulnerability has emerged.  Use of the 
Emotional Inhibition subscale of the ECQ appears to have tapped into this notion with   71 
items  relating  to  remaining  outwardly  calm  despite  experiencing  strong  negative 
emotions  and  the  concept  of  inhibiting  the  expressive  elements  of  emotional 
experiences.    The  mechanism  by  which  emotional  inhibition  is  associated  with  the 
occurrence of behaviours such as sleep walking requires further investigation.  Like, 
insomnia,  however,  it  could  be  considered  in  relation  to  Pennebaker‟s  theory  that 
emotional  inhibition  is  associated  with  increased  stress.    It  is  proposed  that  the 
inhibition  of  expression  of  thoughts  or  feelings  requires  exertion  that  places  a 
cumulative  stress  both  on  the  mind  and  physiologically  resulting  in  stress-related 
physical and psychological health difficulties.  Indeed, this is supported by early studies 
showing that both adults and children with emotional unexpressive tendencies are more 
physiologically reactive to emotional stimuli and later experimental research linking 
emotional suppression to increased autonomic arousal.
54,55 
    
Participants with nREM parasomnias also scored higher on the AAQ-II.  This indicates 
that  in  addition  to  a  tendency  to  inhibit  the  expression  of  emotions,  experiential 
avoidance, referring to a more private construct relating to an individual‟s attempts to 
avoid  the experience of undesirable internal  events,  could  also  be implicated in  the 
presentation of nREM parsasomnias.  There has also been some research into emotional 
avoidance and physiological arousal.  Interestingly, elevated heart rate activity has been 
found in a “high experiential avoidance” group as measured by the AAQ compared to a 
“low experiential avoidance” group during neutral and resting baseline periods but not 
in response to unpleasant stimuli.
56,57  It has been suggested that continuous attempts to 
regulate emotion leads to greater general levels of arousal.
57  It could be suggested that 
emotional inhibition both in terms of its outward expression and experiential avoidance, 
is a factor contributing to the increased arousal levels demonstrated in the population in 
this study, presenting with these “disorders of arousal”.   
 
The  suggestion  that  levels  of  rumination  and  worry  might  be  elevated  in  people 
presenting  with  nREM  parasomnias  arose  from  evidence  in  relation  to  insomnia  as 
opposed to any previous literature specific to this population.  That this hypothesis was 
confirmed indicates that, indeed, certain psychological factors implicated in insomnia 
also appear to be relevant to this sleep disorder.  It could be that such “persevarative” 
cognitions  as  rumination  and  worry  in  people  with  nREM  parasomnias,  like  those 
experiencing  insomnia,  can  be  seen  as  a  form  of  cognitive  arousal  which  are  also 
associated with sympathetic arousal.
58 
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Both cognitive and somatic pre-sleep arousal and trait like arousability, all implicated in 
the  development  and  maintenance  of  insomnia,  were  also  found  to  be  significantly 
higher  in  the  nREM  parasomnia  group  compared  to  good  sleepers.    It  could  be 
postulated that, for example, a vulnerability to arousal developing for psychological 
reasons, such as those uncovered in this study, manifests itself through partial arousals 
out of slow wave sleep in the form of sleepwalking or night terrors.   
   
Although  at  this  stage  it  is  only  possible  to  make  suggestive  statements  about  the 
mechanisms  by  which  the  factors  reported  in  this  study  may  be  influencing  the 
presentation of nREM parasomnia, the results at least suggest that, parallel to insomnia, 
there is a potential interaction between psychological and physiological processes at 
play.  
 
Differences between those with insomnia and nREM parasomnia 
A research question was posed regarding the specificity of the nature and degree of 
psychological measures to the nREM parasomnia group compared with the insomnia 
group.    The  only  significant  difference  uncovered  was  that  of  the  insomnia  group 
reporting higher levels of pre-sleep cognitive arousal than the nREM parasomnia group.  
In previous research, cognitive arousal has been consistently found to be more strongly 
associated with insomnia complaints than somatic arousal.
59,60  It is interesting to note 
here that although both somatic and cognitive arousal was found to be higher in the 
nREM parasomnia group compared to good sleepers, the effect size for the difference in 
the somatic subscale was larger than for the cognitive subscale (Appendix 2.14).  It 
could  be  tentatively  suggested  that  arousal  is  perhaps  more  evident  in  somatic, 
compared with cognitive, symptoms in this group, however more research would be 
required to explore this possibility. 
 
A key finding in this study is that the nREM parasomnia group were found to have 
levels of maladaptive psychological responses that were comparable to the insomnia 
group.  Despite their commonalities as psychophysiological disorders of sleep, however, 
there are distinct differences in how the sleep process is interfered with in insomnia and 
nREM  parasomnias.    nREM  parasomnias  represent  disorders  of  arousal  from  sleep 
rather  than  a  difficulty  initiating  or  maintaining  sleep.    It  is  reasonable  to  suggest 
therefore that there would be some difference in the nature of psychological factors in 
this interference.  If this is the case, the measures used in this study were not sensitive to 
such  differences.    Further  theorising  is  needed  with  regards  to  where  potential 
differences may lie between the two groups.  For example, perhaps there are distinct   73 
vulnerabilities in relation to separate constructs of emotional inhibition whereby one 
may be more associated with a deficit in identifying and expressing emotions such as 
what  is  termed  “alexithymia”  and  the  other  with  a  conscious  emotion  regulation 
strategy.       
 
Further theorising with regards to where potential differences may lie between people 
experiencing these two disorders and the selection of appropriate measurement in its 
investigation  would  help  to  enlighten  this  line  of  enquiry.    For  example,  utilising 
measures of separate constructs of emotional inhibition (e.g. in relation to a deficit vs a 
conscious emotion regulation strategy) may capture distinct vulnerabilities. 
 
The  lack  of  disparity  found  on  the  psychological  measures  between  the  nREM 
parasomnia  and  insomnia  groups  in  this  study  could  also  suggest  that  the  same 
vulnerabilities are present within both sleep disorders but expressed differently.  People 
with insomnia experience a difficulty with down-regulating arousal.  A clear conscious 
self-perpetuating mechanism occurs whereby an individual‟s increased efforts to sleep 
paradoxically inhibits de-arousal and thus sleep.       
 
Perhaps  in  the  case  of  nREM  parasomnias,  similar  vulnerabilities,  such  as  certain 
psychological responses to stress, manifest themselves in arousal from slow wave sleep.  
Unlike those with insomnia, however, due to some form of up-regulation or “anchor” 
into this stage of sleep, preventing the individual from fully wakening, this results in 
only partial arousal from sleep.  There could be some interaction here with specific 
factors implicated in deepening sleep or making arousal from sleep more difficult (e.g. 
sleep  deprivation)  which  could  further  increase  the  chances  of  sleepwalking/night 
terrors (see Pressman, 2007 for a review).
11  The types of behaviours that tend to occur, 
such as walking, eating and in some instances sexual activities, or in the case of night 
terrors,  extreme reflexive emotions  of fear,  appear primitive in  nature.    It  could  be 
postulated that while the primitive, subcortical part of the brain wakes up, other, higher 
functioning aspects of the brain remain in a sleep state.  The potential for parts of the 
brain being “awake” during sleep is in line with the notion of “local sleep”.  Contrary to 
the traditionally held view of the brain as a whole being in distinct states of awake, 
REM and nREM sleep, there is evidence to suggest that sleep is “local” in that at any 
one point in time, electrical markers of sleep can be restricted to certain areas of the 
brain.  Such evidence comes from research examining simultaneously recorded scalp 
EEG,  intracerebral  EEG,  and  unit  firing  in  multiple  brain  regions  of  neurosurgical 
patients and studies of rats showing that, when kept awake beyond their normal sleep   74 
time,  neurons  in  different  cortical  areas  can  suddenly  go  „offline‟  in  a  way  that 
resembles nREM sleep.
61,62  Further research in this area could inform understanding of 
the neurological substrates of nREM parasomnias.   
 
Whereas  the occurrence of insomnia increases  with  age, the opposite is  found with 
nREM parasomnias, which are more common among children and usually “outgrown” 
during  adolescence.    This  typical  developmental  process  could  represent  better 
integration of brain functioning and those individuals who maintain nREM parasomnia 
into adulthood may have a distinctive problem with arousal that is due to a lack of 
maturation in this respect.   
 
For  people  with  insomnia,  the  cognitive  processes  implicated  in  perpetuating  the 
disorder  are  incorporated  into  cognitive  behavioural  interventions  with  effective 
outcomes.   People experiencing nREM parasomnia have  a much less  active role in 
maintaining  their  disorder,  however  treatment  focusing  on  intervening  with  the 
psychological mechanism that could be implicated in the expression of these behaviours 
such as those uncovered in this study could potentially result in elimination or at least 
reduction in their presentation.     Such an approach to intervention is considered below. 
 
Strengths and limitations 
One of the strengths of the study is the strict inclusion criteria that were applied in 
selecting participants, particularly in relation to the nREM parasomnia groups.  Each 
participant underwent a comprehensive screening interview, covering both diagnostic 
criteria for the specific nREM parasomnia reported and an algorithm to confirm no 
symptomatic evidence of another sleep disorder.  This added to the validity of the study 
in ensuring that it could be claimed with a high degree of confidence that those being 
studied did indeed experience this particular phenomenon.  For example, less rigorous 
procedures may have lead to the inclusion of people with other parasomnias such as 
REM sleep behaviour disorder which shares similar features.  Further, discrimination 
from an insomnia group enabled the exploration of possible psychological factors that 
may have been specific to nREM parasomnias as opposed to a sleep disorder per se.  
 
Some limitations, however, are important to outline when interpreting the findings in 
this study.  It should be acknowledged that this study was cross-sectional in design and 
therefore  it  is  not  possible  to  determine  any  causal  relationship  between  nREM 
parasomnias and the psychological factors that were found to be associated with their 
occurrence.  Although it seems more plausible theoretically that such factors would   75 
contribute to, rather than be a result of this phenomena, prospective studies would be 
required to have more confidence in this direction.  The study also relied solely on self-
report for measurements of its outcome variables which entail certain potential biases.  
It could be argued that people may not be able to give an accurate response due to 
cognitive and memory biases, thus measuring an individual‟s perception of a construct 
rather than measuring it directly.  Future studies could employ objective measures, for 
example of physiological arousal or alternative indices of emotional expression such as 
linguistic text analysis.           
 
Further  limitations  relate  to  the  participants  recruited.    The  sample  included  both 
clinical  cases  and  people  from  the  general  population.    It  is  possible  that  clinic 
attendees, for whom nREM parasomnias have caused sufficient disruption in their lives 
so as to seek professional help, may represent a qualitatively different population to 
those who experience nREM parasomnias with no such resulting impact.  Such variance 
in this group was not controlled for in this study. There was also no distinction made 
between  adult  onset  nREM  parasomnias  and  those  who  have  experienced  such 
phenomena since childhood.  Interestingly, the majority of participants in this study had 
experienced their first nREM parasomnia at least by their teenage year.  The finding 
that,  compared  to  controls,  this  group  displayed  higher  levels  of  psychological 
responses  that  are  arguably  maladaptive  in  nature,  goes  contrary  to  Kales‟ 
aforementioned report of more intense clinical manifestations in adult onset compared 
to child onset sleepwalkers.
14  Finally, no attempt was made to investigate differences in 
subtypes of nREM parasomnias on any of the variables.  Including participants who 
experienced both types, 70% of this group experienced night terrors.  Therefore, without 
replication of these results with a greater representation of sleep walkers, there is the 
potential interpretation that the findings are indicative of night terrors as opposed to 
nREM parasomnias more generally.    
          
A final limitation when considering the generalisability of the findings in this study is 
the possibility of a type-II error.  The originality in the focus of this study, while a 
strength, meant there was limited information on which to determine a sample size to 
ensure any differences between the groups would be detected.  Although attempts were 
made to overcome this by aiming to recruit a large sample size of 100 per group in order 
to detect a small to medium effect size, this level of recruitment was not achieved.  
Indeed, where a retrospective power analysis calculation was performed with regards to 
rumination and insomnia, a sample size of only 57 was required to detect a difference 
should it be replicated.  It is possible that, should the targeted sample size have been   76 
achieved, a significant effect would have ensued here, replicating previous findings of 
higher levels of rumination in this group compared to controls.  It should be noted, 
however, that  nonsignificant findings between the two sleep disordered groups were 
generally associated with very small effects sizes, thus increasing confidence that type 
II errors were  not committed in this respect.  Sample size was initially unequal across 
groups, with a disproportionate number of good sleepers.  In removing participants from 
this group to create more even numbers, the opportunity arose to improve matching to 
the nREM parasomnia group, particularly in relation to gender.  It should be noted that 
analysis was not re-run with the inclusion of the 12 participants who had been removed.  
The presence of unequal sample sizes between groups violates assumptions of certain 
statistical analysis and therefore it was considered that repeating the analysis with such 
violations could not be taken as validation of the analysis that was originally conducted.         
 
Implications 
Despite  these  limitations,  the  findings  in  this  study  provide  some  important  initial 
evidence  concerning  psychological  factors  influencing  the  presentation  of  nREM 
parasomnias.  Previous research has provided evidence for biomedical predictors of the 
occurrence of such phenomena including sleep deprivation and alcohol consumption.  
The  diagram  presented  in  Figure  2.6  below  represents  a  potential  starting  block  on 
which further theory could  be built.  The figure incorporates the psychological  and 
physiological  factors  suggested  by  findings  in  this  study  to  be  influencing  the 
presentation of nREM parasomnias, in addition to the biomedical and situational factors 
previously identified.  Further investigation is required into the interplay between these 
factors in contributing to this sleep disorder.  Much understanding of the aetiology and 
maintenance of insomnia has stemmed from psychologists drawing on models from 
other  areas  of  psychology  and  clinical  experience  and  investigating  psychological 
processes in people with insomnia. The findings in this study suggest there may be 
value in approaching the study of people experiencing nREM parasomnias from the 
same perspective.       
 
If  these  findings  are  replicated,  a  greater  emphasis  on  psychological  intervention  is 
implicated as opposed to restriction to the existing medical treatment and behavioural 
and  risk  management  strategies  that  can  be  advised  to  such  sufferers.    nREM 
parasomnias  are  an  unpredictable,  irregular  phenomena  and  not  an  ideal  model  for 
corrective medication which is more suitable for regular symptoms.  Medication such as 
clonazepam and paroxetine have been reported to be effective for nREM parasomnias 
and  can  be  taken  as  a  preventative  measure,  despite  a  low  probability  of  its   77 
presentation.
38  When considering medication as a treatment route, patients with nREM 
parasomnias have to weigh up the risks and benefits of such action and are often put off 
by  potential  side  effects.    As  is  the  case  with  insomnia  sufferers,  psychological 
interventions,  should  they  prove  effective,  could  present  an  appealing  alternative 
treatment  option.    There  has  been  some  promising  development  of  psychological 
interventions  in  the  area  of  parasomnias  occurring  during  REM  sleep  such  as 
nightmares.  CBT treatments here have focused on exposure technique such as writing 
down  nightmares  and  imagery  rehearsal  in  which  the  patient  learns  to  rewrite  and 
engage in imaginal rehearsal of a new version of their dreams which is not distressing.  
These techniques have proved to be effective in improving subjective sleep quality and 
reducing nightmare frequency and psychological distress.
63-65       
 
Further research should involve building on the database thus far developed through this 
study, collecting data for more psychological measures on this client group.  This may 
include,  for  example,  those  relating  to  constructs  of  emotional  expression  such  as 
measures  of  alexithymia,  as  discussed  above,  and  measures  of  other  coping  styles, 
which may shed more light on how such people respond to stress.  Given its relative 
uncommonness, this would be facilitated by multi-centre collaboration.  If the particular 
psychological responses reported here are found to be replicated in future studies then 
interventions specific to these can be developed and evaluated.  In relation to tendencies 
toward  emotional  inhibition,  expressive  writing  tasks  may  be  of  benefit,  whereas 
general cognitive strategies such as cognitive restructuring may help to reduce worry 
(see Appendix 2.16 for structure of a Parasomnia Treatment Programme currently being 
piloted at the UGSC).   
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Figure 2.6 Biomedical, physiological, psychological and situational factors 
in nREM parasomnias 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Conclusions 
Despite  the  limitations  outlined,  this  study  achieved  its  aim  of  providing  some 
preliminary evidence for the implication of psychological factors in the presentation of 
nREM parasomnias.  People experiencing these phenomena were found to experience 
higher levels of emotional inhibition, worry, rumination and arousability relative to a 
control  group  of  good  sleepers.    With  the  exception  of  rumination,  the  study  also 
confirmed and extended findings from previous research that those with insomnia also 
experience  increased  levels  of  these  psychological  variables  relative  to  controls.  
Comparing  the  two  sleep-disordered  groups,  it  was  found  that  the  insomnia  group 
reported higher levels of pre-sleep cognitive arousal.  This has been considered in line 
with  evidence  that  cognitive  arousal  is  more  strongly  associated  with  insomnia 
complaints  than  somatic  arousal  and  is  indicative  of  the  self-perpetuating  cognitive 
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processes  that  maintain  them.    No  other  differences  were  uncovered  and  the 
implications of this was discussed with regards to the possibility that measures used in 
this study were not sensitive to any distinctive psychological processes that are present 
or  that  the  same  vulnerabilities  are  present  in  the  two  groups  but  are  expressed 
differently.    It  is  suggested  that  further  investigation  into  the  interplay  between 
psychological,  physiological  and  biomedical  factors  in  contributing  to  nREM 
parasomnias  is  warranted.    If  the  finding  that  psychological  factors  influence  the 
presentation of this sleep disorder is replicated, weight is given to arguments for the 
development  and  evaluation  of  psychological  interventions  for  such  client  groups, 
which could potentially provide them with an alternative, arguably preferable, treatment 
option to medication.          
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Abstract 
The catalyst for this reflective account was an interaction providing consultation to a 
community nurse.   This experience highlighted some insecurities and assumptions I 
had about justifying the unique contribution that I could bring to a team as a clinical 
psychologist.  Using aspects drawn from three models of reflection, I explore where this 
may have originated from and how my thoughts and feelings have changed with new 
learning experiences.    I refer to the relevant political drivers and policy documents that 
have influenced the ever evolving and multifaceted role of our profession.  I particularly 
consider  the  role  of  providing  consultation  to  other  professions,  promoting 
psychological  understanding  in  teams  and  how  I  can  continue  to  develop  this  skill 
beyond qualification.   This seemed like a pertinent theme for the focus of the present 
account because as my skills and competencies have developed through the course of 
training, my understanding and perspectives have changed.  I conclude the account with 
a reflective review, considering what I have gained from the process of reflection itself 
and how I have found the models beneficial as a guide whilst not being restricted by 
rigid adherence to their structure.  I also critique how my reflections may have been 
improved  and  consider  the  importance  of  continuing  to  make  time  for  structured 
reflective practice in my work.      
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Abstract 
As I approach the end of training I reflect on how to make that transition from trainee to 
qualified  clinician.    I  have  observed  those  already  in  that  role,  inspired  by  the 
contribution  they  make  on  a  regular  basis  to  the  functioning  of  the  team  and  in 
increasing others‟ psychological knowledge through training and consultation.  I have 
chosen to focus this reflective account on what I have learned through these vicarious 
experiences.    I  outline  the  context  within  which  the  direction  of  the  clinical 
psychologist‟s role has moved towards undertaking these leadership tasks and describe 
two  models  that  have  guided  my  reflections.    Reflections  were  stimulated  by  my 
observation of a recently qualified clinical psychologist who provided consultation to a 
colleague and later considered how she might be able to do this more efficiently within 
the  multidisciplinary  team  in  which  we  work.    This  brought  to  my  awareness  the 
apprehension I have previously had at the thought of being expected to fulfil leadership 
tasks at the early stages of my career.  I explore how my understanding of this has 
changed  through  such  observations  and  my  resultant  feelings  of  excitement  and 
eagerness  to  partake  in  these  tasks  in  my  future  work.    I  critique  my  approach  to 
reflecting in this account and how I might improve future reflections by being more 
flexible in my approach.  I consider what I have gained through the process of reflecting 
on this particular topic and my thoughts in relation to the political context outlined 
earlier in the account.    
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APPENDIX 1.2 
Table presenting studies excluded on reading full article 
Study  Reasons for exclusion 
Augustsdoftir et al 2010  Emotional  expression  investigated  as  a  moderator 
variable 
    
Ando et al 2009  Investigating  patients  attending  for  screening,  not 
necessarily diagnosed with cancer 
    
Hyphantis et al 2011  Investigating  emotional  expression  compared  to  other 
coping  strategies  as  opposed  to  levels  of  emotional 
expression 
    
Burns et al 2006  Emotional  expression  investigated  as  a  moderator 
variable    
    
Hann et al 2008  “Breast  cancer  concerns”  as  opposed  to  psychological 
adjustment as outcome measure   
    
Harila et al 2011  Not measuring emotional expression as an independent 
variable 
    
Ripetti et al 2008  Quality  of  life  measured  as  outcome,    psychological 
adjustment not analysed separately  
    
Verdonck-De Leeuw et al 2007  Investigating  emotional  expression  compared  to  other 
coping  strategies  as  opposed  to  levels  of  emotional 
expression   
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APPENDIX 1.3  
Methodological quality rating scale 
 
Quality Criteria 
Score  
0  1   2 
Study objectives… 
1) Are the study objectives clearly 
outlined? 
Neither aims or hypotheses stated = 
0 
Aims but not hypotheses stated = 1  
Aims and hypotheses stated = 2 
     
Study design ….. 
2) What is the design of the study?  
Cross-sectional design = 1  
Longitudinal element to design = 2  
     
Selection of participants… 
3)  Are  the  inclusion/exclusion 
criteria clearly stated?  
Not reported = 0  
Referred to but not defined = 1  
Clearly defined =  2  
     
4) Is the recruitment process clearly 
described? 
Not reported = 0 
Partially reported = 1  
Clearly reported = 2  
       95 
Participant characteristics … 
5) Are participant‟ characteristics 
clearly reported? (age, gender, 
socioeconomic status/ethnicity, 
cancer  type)  
None of the characteristics reported 
= 0  
Some characteristics reported = 1  
All characteristics reported = 2 
     
6) Are the main potential 
confounders identified and taken 
into account in the design and 
analysis?  
No = 0  
Yes = 1  
     
Independent variable 
measurement… 
7)How was emotional 
expression/non-expression 
measured?  
Non standardised self-
report/linguistic indicator measure 
(or details of psychological 
properties not reported) = 0 
Standardised self-report/measure of 
linguistic indicator with details of 
psychometric properties reported 
from other studies with different 
populations  = 1  
Standardised self-report/ measure of 
linguistic indicator with details of 
psychometric properties provided 
within the condition-specific 
population = 2  
       96 
Outcome measurement…. 
8)How was psychological 
adjustment measured?  
Non standardised self-report 
measure (or details of psychological 
properties not reported)  = 0 
Standardised self-report measure 
with details of psychometric 
properties reported from other 
studies with different populations  = 
1  
Standardised self-report measure 
with details of psychometric 
properties provided within the 
condition-specific population = 2  
     
Statistical analysis and results…. 
9) Was a power calculation used to 
justify sample size?  
No = 0  
Yes = 1  
     
10) Was the statistical analysis 
stated clearly? 
Not stated = 0  
Stated but not appropriate to design 
= 1  
Stated and appropriate to design = 2   
     
11) Were results clearly reported, 
with confidence intervals, effect 
sizes, p-values etc provided where 
appropriate?  
Not reported =  0  
Partially reported = 1  
Fully reported  = 2  
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Quality rating:  
High = > 75%  
Medium = > 50%  
Low = < 50%  
 
Total Quality rating score  (out of a  possible 21 ) =  
Percentage =              %  
Quality Rating =  
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APENDIX 2.1 
Author Guidelines for submission to Sleep 
 
 
Full details at http://www.journalsleep.org/AuthorInfo.aspx 
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APENDIX 2.2 
 Case illustration of nREM parasomnia 
 
Case Example  
An 18 –year old white youth who resides in a rural Midwestern farming community is 
academically doing well as a senior in high school.  The patient reluctantly presented to 
the Sleep Center upon the insistence of his mother, who has had increasing concerns 
over her only child‟s safety, particularly at night.  According to his parents, since 
childhood their son has had nocturnal episodes arising within a few hours after sleep 
onset.  Believing that these would resolve as their son grew out of adolescence and into 
adulthood, the parents were at first not overly concerned and were able to maintain their 
son‟s safety by remaining vigilant and subtly intervening when necessary.  the patient‟s 
nocturnal activities have maintained their almost nightly regularity, but they have 
developed into occasionally more complex, sustained, and violent actions.  The patient 
has grown to 77 inches tall and a weight of 225 pounds, so it is not surprising that 
parental interventions to quell their son‟s suddenly unmanageable nocturnal activities 
have become problematic for both parties. 
 
The patient states that he has always been completely unaware of these episodes and has 
no recollection of the events the following morning.  The parents are further concerned 
for their son‟s safety because he intends to enrol in a college away from home and is 
looking forward to living in either a dormitory or a high-rise apartment.  Without the 
vigilance of responsible persons in college, the parents fear the worst for their son.  Of 
course the patient, wanting to exert his independence and lacking proper insight into the 
gravity of his situation, clearly had become antagonistic over his parents‟ concerns. 
 
The patient‟s continued lack of awareness in these matters coupled with his sincere 
denial of any difficulties with either sleep initiation or maintenance made the direct 
involvement of the patient‟s parents crucial in attaining a comprehensive history as well 
as a thorough clinical characterization of the patient‟s behaviour in sleep.  According to 
his mother, since childhood the patient has had “sleep disturbances” almost every night.  
Typically, these episodes occur within the first two hours after he has gone to bed, and 
only rarely do they occur in the latter third of the night.  The episodes are characterized 
by somniloquy, somnambulism, and a general “thrashing around in his bed,” leaving his 
bedding in complete disarray.  Less frequently, the patient would abruptly wake up the 
household with fits of “screaming and yelling at the top of his lungs.”  Despite his 
parent‟s efforts at reassurance and solace, the patient remained unreceptive and 
inconsolable.  Just as these “night terrors,” as the mother called them, came on 
suddenly, so too would they spontaneously abate. 
 
Although the patient‟s nocturnal activities were unremitting in frequency over recent 
years, his parents began to discern a trend toward more worrisome physical behaviour.  
These particular “severe” episodes were punctuated by violent outbursts of punching, 
hitting and kicking inflicted upon a foe in the room but unseen to his parents.  Never at 
any time were these combative actions directed towards his parents.  Many times over 
recent years the patient was caught trying to get out through the front door although he 
was visibly asleep.  On one occasion the mother caught her son just as he was 
attempting to leave through an upstairs window, having “already completely kicked out 
the storm window.”  In the last two years, it has not been uncommon for the patient to 
sustain bruises and superficial cuts to his extremities as a result of these nocturnal 
activities.  Lastly, the parents note that these “severe” episodes increase in frequency 
when the patient is staying away from home such as in a hotel or in summer camp. 
   100 
Aside from a delayed form of delayed sleep-phase syndrome and consequent volitional 
sleep deprivation supported by three weeks of sleep diaries, the patient has otherwise 
been absolutely healthy and has not suffered from any medical, neurological or mental 
conditions.  The patient does not drink alcohol nor does he partake of illicit drugs. The 
patient does not take any prescribed medications, including selective serotonin reuptake 
inhibitors.  The patient does not have a history suggesting sleep-disordered breathing or 
any other primary sleep disorder.  Family history is devoid of any nocturnal behaviour 
suggestive of parasomnias. 
 
Formal nocturnal polysomnography was undertaken using a full seizure montage.  The 
baseline polysomnogram did not reveal any sleep-disordered breathing, nocturnal 
myoclonus or periodic limb movements.  Sleep architecture was within normal limits 
and the patient attained a sleep efficiency of 99%.  REM stage was attained and 
observed to have normal atonia.  A full seizure montage showed no electrical or clinical 
seizure activity.  Four discrete episodes of spontaneous NREM-related confusional 
arousals were observed and were associated with complex motor activity (fig 74-1) and 
overt vocalizations.  These confusional arousals were not associated with consequent 
EEG slowing.   
 
As suspected by the clinical history and further supported by the findings on the 
polysomnogram, the patient‟s problem was diagnosed as an NREM parasomnia.  The 
patient developed a better understanding of his problem after we replayed his findings 
on the video monitor.  Management strategies included: 
 
employing proper sleep hygiene and minimizing volitional sleep deprivation; 
continuing to refrain from or minimizing alcohol use; 
ensuring a supportive environment with appropriate responsible vigilance; provided by 
a team of family and friends; 
ensuring safety by, among other measures , attaining housing on the ground level or 
basement of his chosen residence; 
taking a long-acting sedative hypnotic of the benzodiapazine class every night. 
 
 
 
 
 
Copied from Mahowald, MW & Bornemann, MAC,  NREM Sleep-Arousal Parasomnias. In 
Kryger,  MH,  Roth  T,  Dement  WC,  eds.    Principles  of  Sleep  Medicine,  4th  edition. 
Philadelphia, PA: Elsevier Saunders; 2005: 889-896.   
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APPENDIX 2.3 
ICSD-2 Diagnostic Criteria for Insomnia and nREM Parasomnia Groups 
 
Participants in the insomnia group met the following criteria as described in the ICSD-2 
diagnostic classification system: 
 
General Criteria for Insomnia 
 
A.  A complaint of difficulty initiating sleep, difficulty maintaining sleep, or waking up too 
early or sleep that is chronically non-restorative or poor in quality. 
B.  The above sleep difficulty occurs despite adequate opportunity and circumstances for 
sleep. 
C.  At least one of the following forms of daytime impairment related to the night time 
sleep difficulty is reported by the patient: 
i.  Fatigue or malaise 
ii.  Attention, concentration, or ,memory impairment 
iii.  Social or vocational dysfunction 
iv.  Mood disturbance or irritability 
v.  Daytime sleepiness 
vi.  Motivation, energy, or initiative reduction 
vii. Proneness for errors or accidents at work or while driving 
viii.  Tension, headaches, or gastrointestinal symptoms in response to sleep loss 
ix.  Concerns or worries about sleep 
 
Participants in the NREM parasomnia group met the following ICSD-2 diagnostic criteria 
for Disorders of Arousal (from NREM Sleep). 
 
Sleepwalking 
A.  Ambulation occurs during sleep. 
B.  Persistence of sleep, an altered state of consciousness, or impaired judgment during 
ambulation is demonstrated by at least one of the following: 
i.  Difficulty in arousing the person 
ii.  Mental confusion when awakened from an episode 
iii.  Amnesia (complete or partial) from an episode 
iv.  Routine behaviours that occur at inappropriate times 
v.  Inappropriate or nonsensical behaviours 
vi.  Dangerous or potentially dangerous behaviours 
C.  The  disturbance  is  not  better  explained  by  another  sleep  disorder,  medical  or 
neurological disorder, mental disorder, medication use, or substance use disorder. 
Night Terrors 
A.  A sudden episode of terror occurs during sleep, usually initiated by a cry or loud scream 
that is accompanied by autonomic nervous system and behavioural manifestations of 
intense fear. 
B.  At least one of the following associated features is present: 
i.  Difficulty in arousing the person 
ii.  Mental confusion when awakened from an episode 
iii.  Amnesia (complete or partial) for the episode 
iv.  Dangerous or potentially dangerous behaviours 
C.  The  disturbance  is  not  better  explained  by  another  sleep  disorder,  medical  or 
neurological disorder, mental disorder, medication use, or substance use disorder 
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APPENDIX 2.4 
UGSC Screening Interview 
 
Participant ref no:  
 
 
Today’s date:  
 
Source (to be answered by all participants) 
 
How did you find out about the University of 
Glasgow Sleep Centre? 
 
Why have you contacted us?   
Method of initial contact (e.g. mobile, email) 
 
 
 
Personal (to be answered by all participants) 
 
Full Name: 
 
Date of Birth:  Age: 
Telephone (home, mobile): 
 
 
Address: 
 
 
 
 
 
Postcode: 
Email: 
 
When is a good time to call? 
What GP practice do you attend, and who is 
the GP you normally see? 
 
 
 
 
Do you give your consent for us to contact your 
GP if necessary regarding your health? 
 
 
 
Do you have difficulty sleeping at the moment? (Y/N) 
 
Are you generally satisfied with the amount of sleep you get (Y/N) 
Do you work shifts, night shifts? 
 
Are you aware of any other family members with a sleep disorder? 
 
If yes please specify: 
 
 
 
 
E.g. Do either of your parents have sleep difficulties (now or in the past)?  
What about brothers and sisters?  
What about extended family including grandparents?  
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Health (to be answered by all participants) 
Do you keep in good health physically? (Y/N) 
 
What physical health problems do you have (if applicable)? 
(Could your sleep difficulties be due to any other physical health problems or medication use?) 
What medicines do you take for your physical health? (if applicable) 
 
 
Roughly, how many units of alcohol do you drink per week?     
(Standard (175ml) glass of wine = 2 unit;  One pint of standard lager = 2.3  units;  Spirit & Mixer   = 
1 unit) 
 
 
 
Do you take recreational drugs? If so, how often? (e.g. once per week/month etc) 
 
Do you keep in good health mentally? (Y/N) 
 
What mental health  problems do you have (if applicable)? 
 
 
What medicines do you take for your mental health? (if applicable) 
 
 
 
 
Screen for Possible Sleep Disorders Other Than Insomnia.  
(to be answered by all participants) 
 
1. Narcolepsy 
a. Do you sometimes fall asleep in the daytime completely without warning? (YES/NO) 
If Yes…. 
b. Is it literally impossible to resist ‘sleep attacks’ during the day? 
c. Do you have collapses or extreme muscle weakness triggered by extreme emotion? 
d. Do you have visual hallucinations, either just as you fall asleep or when you wake in the morning? 
e. Are you paralysed and unable to move when you wake up from your sleep? 
 
[OFFICE USE ONLY: Possible narcolepsy: 1a¼‘‘TRUE’’ AND (1b OR 1c OR 1d OR 1e¼‘‘TRUE’’)]  
 
2. Sleep breathing disorder 
a. Are you a very heavy snorer? (YES/NO) 
If Yes… 
b. Does your partner say that you sometimes stop breathing? 
c. Do you often wake up gasping for a breath? 
d. Are you often excessively sleepy during the day or fall asleep without wanting to? 
 
[OFFICE USE ONLY: Possible sleep breathing disorder: 2a¼‘‘TRUE’’ AND (2b OR 2c OR 2d¼‘‘TRUE’’)]   104 
3. PLMS/ RLS 
a. Do your legs often twitch or jerk or can’t keep still in bed?(YES/NO) 
If Yes… 
b. Is it very difficult to get to sleep because of repeated muscle jerks? 
c. Do you frequently wake from sleep with sudden jerky movements or with a compulsion to move your 
legs? 
d. Do you simply have to get out of bed and pace around to get rid of these feelings? 
 
[OFFICE USE ONLY: Possible PLMS/ RLS: 3a¼‘‘TRUE’’ AND (3b OR 3c OR 3d¼‘‘TRUE’’)] 
 
4. Circadian Rhythm Sleep Disorder 
a. Do you tend to sleep well but just at the ‘‘wrong times’’? (YES/NO) 
If Yes… 
b. Can you sleep well enough, but only if you stay up very late? 
c. Are you in a very sound sleep at normal waking time and could sleep on for hours more? 
d. Can you sleep well enough, but only if you go to bed very early? 
e. Do you wake very early, bright and alert and no longer sleepy? 
 
[OFFICE USE ONLY: Possible CRSD: 4a¼‘‘TRUE’’ AND EITHER (4b AND 4c¼‘‘TRUE’’) OR (4d AND 4e¼‘‘TRUE’’)] 
 
5. Parasomnia 
a. Do you have unusual behaviours, like sleepwalking,  associated with your sleep that trouble you 
or that are dangerous?(YES/NO) 
If Yes… 
b. Do you sleepwalk frequently and run the risk of injuring yourself or others? 
c. Do you have frequent night terrors when you are extremely distressed but not properly awake? 
d. Do you act out your dreams and risk injuring yourself or others? 
e. Do you have terrible recurring nightmares? 
 
[OFFICE USE ONLY:  Possible parasomnia: 5a¼‘‘TRUE’’ AND EITHER (5b OR 5c OR 5d OR 5e¼‘‘TRUE’’ 
 
If YES to b. or c. 
  Do you currently experience these?(YES/NO) 
  How often in the past 6 months? 
 
 
Insomnia (if applicable) 
Have you always been a poor sleeper? (Y/N) 
 
How long have you had a sleep problem?(yr) 
Do you have difficulty falling asleep? (Y/N)  
How many nights per week do you have difficulty falling asleep? (out of 7)  
How long does it normally take you to fall asleep?(min) 
 
Do you experience sleep disturbance because of waking during the night?(Y/N) 
How many nights per week do you have a difficulty with waking up during the night?(out of 7) 
How long are you normally awake during the night, in total? (min) 
 
What time do you normally go to bed? (time)  
What time do you normally get up?(time) 
 
How long do you normally sleep?(hr/min) 
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Sleepwalking (if applicable) 
Do you sleep walk or carry out any other activities during sleep.   Please describe any activities that 
occur in addition to walking (e.g. eating, sex, undressing/.dressing)? 
 
 
 
Is it difficult to arouse you from the sleep state during these events? 
 
Have you experienced mental confusion when awakened from an episode? 
Do you have any memory of such events upon awakening?  
How often do these events occur in general (e.g. once per week/once per month)? 
 
How many in last 6 months? 
How long ago did you last experience this event?   
Approximately how old were you when you first experienced an event like this?  
Do you know whether this occurs at the beginning, middle or end of your sleep?  
 
Night Terrors (if applicable) 
Do you experience sudden episodes of intense terror during sleep? 
 
Do you engage in any dangerous or potentially dangerous behaviours at these times? (if so, please 
describe) 
 
Do you have any memory of such events upon awakening?  
Is it difficult to arouse you from the sleep state during these events? 
Have you experienced mental confusion when awakened from an episode?  
How often do these events occur in general (e.g. once per week/once per month)? 
How long ago did you last experience this event?  
Approximately how old were you when you first experienced an event like this?  
Do you know whether this occurs at the beginning, middle or end of your sleep?  
 
All Sleep Disorders (to be answered by those with a sleep disorder) 
Does your sleep disturbance affect how you feel and function during the day (e.g. fatigue, sleepiness, 
concentration, memory, mood, motivation, irritable, work/social functioning etc.).  If yes, specify most 
salient.  
 
 
Other Studies (to be answered by all participants) 
We are also running a lab based study.  Would you be interested in being contacted about this study?  
If you are not suitable for any of the studies ongoing at the moment are you happy for your details to be kept on a 
database so that you may be contacted in the future should a suitable study start? 
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APPENDIX 2.5 
Participant Information Sheet 
￿           
   
PSYCHOLOGICAL  PROCESSES  IN  ADULTS  WITH  NON-REM 
PARASOMNIAS, INSOMNIA AND GOOD SLEEPERS 
 
PARTICIPANT INFORMATION SHEET  
My name is Katherine Hooker.  I am a trainee clinical psychologist from the University 
of  Glasgow  working  with  Professor  Colin  A.  Espie,  Director  of  the  University  of 
Glasgow Sleep Centre.  I would like to invite you to take part in a study looking at 
psychological  processes  in  people  who  experience  sleep  walking  and  night  terrors 
which are sleep disorders collectively known as non-REM parasomnias.  The study will 
also be investigating these processes in people who suffer from insomnia as well as 
good sleepers.   
 
Before you decide whether or not to take part, it is important for you to understand why 
the research is being carried out and what it will involve.  Please take your time to read 
the following information carefully.  If there is anything that is unclear or if you would 
like more information, please let me know.  Take your time to decide whether or not 
you wish to take part.   
 
What is the title of this project?  
Rumination,  worry,  emotional  inhibition  &  arousability  in  adults  with  non-REM 
parasomnias, insomnia & good sleepers 
 
Why is the study important?  
The current research investigating psychological processes in people with non-REM 
parasomnias (e.g. sleep walking, night terrors) is limited.  Comparing people with non-
REM parasomnias to those with Insomnia as well as good sleepers will help build on 
what we do know and may be relevant to developing appropriate treatments in this area.    
 
What are the aims of this study?  
The study aims to compare people with non-REM parasomnias with people suffering 
from  insomnia  and  good  sleepers  on  self-report  measures  of  various  psychological 
processes. 
 
Who can take part in this study?  
Men and women over the age of 18 who experience sleep walking or night terrors, 
suffer from insomnia or consider themselves to be satisfied with the amount of sleep 
they get.     
 
People who experience any other sleep disorder (for example, sleep apnoea or periodic 
limb movement disorder) will not be able to take part.  Those whose sleep disturbance 
is due to a psychiatric, medical or neurological condition will not be able to take part.  It 
will  not  be  possible  for  somebody  to  take  part  if  they  experience  both  non-REM  
parasomnias AND insomnia.  People will not be able to take part if English is not their 
first language.  Those with significant drug or alcohol use will also be excluded. 
 
Do I have to take part?  
You do not have to take part in this study.  Participation is entirely voluntary.  If you do 
decide to take part you will be given this information sheet to keep and be asked to   107 
sign a consent form.  If you decide to take part you are still free to come out of the study 
at any time without giving a reason.  
 
What does participation in this study involve?  
If  you decide to  take part,  you will be  given the option of doing so  in one of the 
following ways depending on what is more convenient for you: 
 
  By completing a set of questionnaires which would be sent to you by post and 
can be returned in a stamped addressed envelope provided.  
  By completing this same set of questionnaires  online via a website link that 
would be emailed to you. 
  By answering the same questions in an interview by arranging either a telephone 
call or a face-to-face interview at the University of Glasgow Sleep Centre. 
 
It usually takes approximately 20 minutes to complete this set of questionnaires.    
  
What will happen to all of the information?  
All of the information collected about you during the research study will be kept strictly 
confidential.  Personal details (such as your name and address) will not be stored on 
computer, so that you cannot be recognised from it.  If during the study a pre-existing 
but previously undiagnosed condition comes to light then your GP would be informed.  
 
Written feedback will be provided to those who request it following completion of the 
study. 
 
Who is supervising for this study?  
My  research  supervisor,  Professor  Colin  Espie,  who  works  for  the  University  of 
Glasgow, will supervise me. 
 
Who is paying for this study?  
This study is being funded through the University of Glasgow and has been reviewed by 
a Research Ethics Committee.  The committee has approved the research as appropriate. 
 
What if something goes wrong? 
If you wish to complain, or have any concerns about any aspect of the way you have 
been  approached  or  treated  during  the  course  of  this  study,  you  can  contact  my 
supervisor, Professor Colin Espie at the University of Glasgow (Tel: 0141 232 7699), 
who will be able to advise you on the appropriate complaints procedure, should you 
wish to use this. 
 
What should I do if I have any questions about this study?  
If you would like further details about the study, you can either contact me by phone or 
email.   
 
What do I do now if I want to take part in this study?  
If you decide that you would like to take part in the study you can either contact me on 
07788943028  or  email  glasgowsleepcentre@clinmed.gla.ac.uk.    If  you  decide  you 
don‟t want to, there is no need to reply. 
 
You  are  under  no  obligation  to  take  part;  participation  in  this  study  is  completely 
voluntary.  You do not have to give a reason for not wanting to take part in this study.   
 
I would like to take this opportunity to thank you for your time and consideration  
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APPENDIX 2.6 
 
Participant Consent Form 
 
 
 
 
 
 
 
 
 
Participant Identification Number:  
 
CONSENT FORM 
 
Title of Project: Rumination, worry, emotional inhibition & arousability in adults with 
NREM parasomnias, insomnia & good sleepers 
 
Name of Researcher: Katherine Hooker  
Please initial box  
 
1.  I confirm that I have read and understand the information sheet dated 16
th November 2010  
(version 2) for the above study. I have had the opportunity to consider the,  
  information, ask questions and have had these answered satisfactorily.  
 
2.   I understand that my participation is voluntary and that I am free to withdraw at any time  
without giving any reason, without my medical care or legal rights being affected.  
 
3.   I understand that data collected during the study may be looked at by individuals from the 
     University of Glasgow, from regulatory authorities or from the NHS Trust, where it is  
   relevant to my taking part in this research.  I give permission for these individuals to have 
   access to my records.  
 
 
4.  I give consent for my GP to be contacted if an undiagnosed medical condition is suspected.   
 
 
5.   I agree to take part in the above study.  
 
_____________________  ________________   __________________________  
Name of Participant    Date       Signature  
 
 
_____________________   ________________   __________________________  
Name of Person     Date       Signature  
taking consent  
 
When completed, 1 for patient; 1 (original) for researcher site file 
 
 
 
 
 
 
University of Glasgow Sleep Centre 
Sachler Institute of Psychobiological 
Research  
Southern General Hospital 
Glasgow G51 4TF   
Tel: 0141 232 7699 
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APPENDIX 2.7 
Image of online survey site homepage 
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APPENDIX 2.8 
Measures 
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Sleep Condition Indicator 
   112     113 
 
 
 
 
The Impact of Poor Sleep  
 
Over the last month to what extent has poor sleep troubled you in general?  
 
Not at all 
   
   A little 
 
 
 
   Somewhat 
   
Much 
   
  Very Much 
 
 
       
 
 
More specifically, to what extent has poor sleep affected……… 
 
…..your mood?       
 
 Not at all 
   
   A little 
 
 
 
   Somewhat 
   
Much 
   
  Very Much 
 
 
 
…..your energy? 
 
 Not at all 
   
   A little 
 
 
 
   Somewhat 
   
Much 
   
  Very Much 
 
 
 
…..your relationships? 
 
Not at all 
   
   A little 
 
 
 
   Somewhat 
   
Much 
   
  Very Much 
 
 
 
……your ability to stay awake during the day? 
 
 Not at all 
   
   A little 
 
 
 
   Somewhat 
   
Much 
   
  Very Much 
 
 
 
…….your concentration?  
 
 Not at all 
   
   A little 
 
 
 
   Somewhat 
   
Much 
   
  Very Much 
 
 
 
……..your ability to get through your work? 
 
 Not at all 
   
   A little 
 
 
 
   Somewhat 
   
Much 
   
  Very Much 
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ECQ: How we deal with our feelings 
 
 
 
Instructions: Please indicate how you feel about each item by circling either “True” or “False”.  If you 
feel that an item is neither entirely true nor false, please choose the alternative that is most like you.  If 
you haven‟t been in the situation described, please say how you feel you would behave in that situation. 
 
1.  When someone upsets me, I try to hide my feelings.        True      False 
2.  I remember things that upset me or make me angry for a long time afterwards.  True      False 
3.  People find it difficult to tell whether I‟m excited about something or not.    True      False 
4.  I find it difficult to comfort people who have been upset.        True      False 
5.  I generally don‟t bear a grudge – when something is over, it‟s over, and I don‟t  True      False  
  think about it again. 
6.  When something upsets me I prefer to talk to someone about it than to bottle it up.  True      False 
7.  I get “worked up” just thinking about things that have upset me in the past.    True      False 
8.  If I receive bad news in front of others I usually try to hide how I feel.    True      False 
9.  I seldom show how I feel about things.            True      False 
10.  I often find myself thinking over and over about things that have made me angry.  True      False 
11.  If I‟m pleasantly surprised, I show immediately how pleased I am.      True      False 
12.  If I get angry or upset I usually say how I feel.          True      False 
13.  I can usually settle things quickly and be friendly again after an argument.    True      False 
14.  I don‟t feel embarrassed about expressing my feelings.        True      False 
15.  If I see or hear about an accident, I find myself thinking about something similar  True      False 
  happening to me or to people close to me. 
16.  I think about ways of getting back at people who have made me angry long after  True      False 
  the event has happened. 
17.  I never forget people making me angry or upset, even about small things.    True      False 
18.  I think people show their feelings too easily.          True      False 
19.  I find it hard to get thoughts about things that have upset me out of my mind.  True      False 
20.  I often daydream about situations where I‟m getting my own back at people.    True      False 
21.  Expressing my feelings makes me feel very vulnerable and anxious.    True      False 
22.  If I see something that frightens or upsets me, the image of it stays in my mind   True      False 
  for a long time afterwards. 
23.  Thinking about upsetting things just seems to keep them going, so I try to put   True      False 
  them out of my mind. 
24.  I usually manage to remain outwardly calm, even though I may be churned up  True      False  
  inside. 
25.  If I lose out on something, I get over it quickly.          True      False 
26.  I can‟t help showing how I feel, even when it isn‟t appropriate to do so.    True      False 
27.  If I have to confront someone, I try not to think too much about it beforehand.  True      False 
28.  Sometimes I just can‟t control my feelings.          True      False 
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SLEEP AROUSAL SCALE (SAS)  (* = cognitive subscale items) 
 
Please describe how intensely you experience each of the symptoms mentioned below 
as you attempt to fall asleep or to return to sleep, by circling the appropriate number  
 
  Not at all  Slightly  Moderately  A lot  Extremely 
1.Worry about 
falling asleep*  
1  2  3  4  5 
2.Review or 
ponder the 
events of the 
day* 
1  2  3  4  5 
3.Depressing or 
anxious 
thoughts*  
1  2  3  4  5 
4.Worry about 
problems other 
than sleep*  
1  2  3  4  5 
5.Being mentally 
alert, active* 
1  2  3  4  5 
6.Can‟t shut off 
your thoughts* 
1  2  3  4  5 
7.Thoughts keep 
running through 
your head* 
1  2  3  4  5 
8.Being 
distracted by 
sounds, noise in 
the environment* 
1  2  3  4  5 
9.Heart racing, 
pounding or 
beating 
irregularly  
1  2  3  4  5 
10.A jittery, 
nervous feeling 
in your body 
1  2  3  4  5 
11.Shortness of 
breath or labored 
breathing  
1  2  3  4  5 
12.A tight, tense 
feeling in your 
muscles 
1  2  3  4  5 
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  Not at all  Slightly  Moderately  A lot  Extremely 
13.Cold feelings 
in your hands, 
feet or your body 
in general  
1  2  3  4  5 
14.Have stomach 
upset (knot or 
nervous feeling 
in stomach, 
heartburn, 
nausea, gas etc)  
1  2  3  4  5 
15.Perspiration 
in palms of your 
hands or other 
parts of your 
body 
1  2  3  4  5 
16.Dry feeling in 
mouth or throat  
1  2  3  4  5 
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APPENDIX 2.9 
Supplementary analysis: Post-hoc and ANCOVA 
Post-hoc analysis  
Sample characteristics: parametric  
Multiple Comparisons 
Age (years) 
Bonferroni 
(I) 1=Good Sleeper; 
2=Insomnia; 3=NREM 
Parasomnia 
(J) 1=Good 
Sleeper; 
2=Insomnia; 
3=NREM 
Parasomnia 
Mean 
Difference 
(I-J) 
Std. 
Error  Sig. 
95% Confidence 
Interval 
Lower 
Bound 
Upper 
Bound 
Good Sleeper  Insomnia  -11.020
*  2.536  .000  -17.16  -4.88 
NREM 
Parasomnia 
4.165  2.562  .319  -2.04  10.37 
Insomnia  Good Sleeper  11.020
*  2.536  .000  4.88  17.16 
NREM 
Parasomnia 
15.185
*  2.562  .000  8.98  21.39 
NREM Parasomnia  Good Sleeper  -4.165  2.562  .319  -10.37  2.04 
Insomnia  -15.185
*  2.562  .000  -21.39  -8.98 
*. The mean difference is significant at the 0.05 level. 
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Sleep and clinical data: Parametric  
  
 
 
Sleep and clinical data: non-parametric post-hoc pairwise comparisons (Mann-
Whitney)  
 
Ranks 
  1=Good Sleeper; 
2=Insomnia; 3=NREM 
Parasomnia  N  Mean Rank  Sum of Ranks 
SCI Score = 1a + 1b + 1c + 
2 + 3a + 3b + 4 + 5 only  (0 - 
32) 
Good Sleeper  50  25.71  1285.50 
Insomnia  50  75.29  3764.50 
Total  100     
 
Multiple Comparisons 
Bonferroni 
Dependent 
Variable 
(I) 1=Good 
Sleeper; 
2=Insomnia; 
3=NREM 
Parasomnia 
(J) 1=Good 
Sleeper; 
2=Insomnia; 
3=NREM 
Parasomnia 
Mean 
Difference 
(I-J) 
Std. 
Error  Sig. 
97.5% Confidence 
Interval 
Lower 
Bound 
Upper 
Bound 
PSQItransformed  Good Sleeper  Insomnia  -1.86616
*  .12387  .000  -2.1975  -1.5348 
NREM 
Parasomnia 
-1.02129
*  .12515  .000  -1.3561  -.6865 
Insomnia  Good Sleeper  1.86616
*  .12387  .000  1.5348  2.1975 
NREM 
Parasomnia 
.84487
*  .12515  .000  .5101  1.1796 
NREM 
Parasomnia 
Good Sleeper  1.02129
*  .12515  .000  .6865  1.3561 
Insomnia  -.84487
*  .12515  .000  -1.1796  -.5101 
Impacttransformed  Good Sleeper  Insomnia  -2.56299
*  .22152  .000  -3.1556  -1.9704 
NREM 
Parasomnia 
-2.18849
*  .22382  .000  -2.7872  -1.5898 
Insomnia  Good Sleeper  2.56299
*  .22152  .000  1.9704  3.1556 
NREM 
Parasomnia 
.37451  .22382  .289  -.2242  .9732 
NREM 
Parasomnia 
Good Sleeper  2.18849
*  .22382  .000  1.5898  2.7872 
Insomnia  -.37451  .22382  .289  -.9732  .2242 
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Test Statistics
a 
 
SCI Score = 1a 
+ 1b + 1c + 2 + 
3a + 3b + 4 + 5 
only  (0 - 32) 
Mann-Whitney U  10.500 
Wilcoxon W  1285.500 
Z  -8.577 
Asymp. Sig. (2-tailed)  .000 
a. Grouping Variable: 1=Good Sleeper; 
2=Insomnia; 3=NREM Parasomnia 
 
 
Ranks 
  1=Good Sleeper; 
2=Insomnia; 3=NREM 
Parasomnia  N  Mean Rank  Sum of Ranks 
SCI Score = 1a + 1b + 1c + 
2 + 3a + 3b + 4 + 5 only  (0 - 
32) 
Insomnia  50  62.66  3133.00 
NREM Parasomnia  48  35.79  1718.00 
Total  98     
 
 
Test Statistics
a 
 
SCI Score = 1a 
+ 1b + 1c + 2 + 
3a + 3b + 4 + 5 
only  (0 - 32) 
Mann-Whitney U  542.000 
Wilcoxon W  1718.000 
Z  -4.684 
Asymp. Sig. (2-tailed)  .000 
 
 
Ranks 
  1=Good Sleeper; 
2=Insomnia; 3=NREM 
Parasomnia  N  Mean Rank  Sum of Ranks 
SCI Score = 1a + 1b + 1c + 
2 + 3a + 3b + 4 + 5 only  (0 - 
32) 
Good Sleeper  50  27.52  1376.00 
NREM Parasomnia  48  72.40  3475.00 
Total  98       124 
 
Test Statistics
a 
 
SCI Score = 1a 
+ 1b + 1c + 2 + 
3a + 3b + 4 + 5 
only  (0 - 32) 
Mann-Whitney U  101.000 
Wilcoxon W  1376.000 
Z  -7.842 
Asymp. Sig. (2-tailed)  .000 
a. Grouping Variable: 1=Good Sleeper; 
2=Insomnia; 3=NREM Parasomnia 
 
 
Ranks 
  1=Good Sleeper; 
2=Insomnia; 3=NREM 
Parasomnia  N  Mean Rank  Sum of Ranks 
DASS Depression Score  Good Sleeper  50  33.70  1685.00 
Insomnia  50  67.30  3365.00 
Total  100     
DASS Anxiety Score  Good Sleeper  50  31.11  1555.50 
Insomnia  50  69.89  3494.50 
Total  100     
DASS Stress Score  Good Sleeper  50  32.04  1602.00 
Insomnia  50  68.96  3448.00 
Total  100     
 
 
Test Statistics
a 
 
DASS 
Depression 
Score 
DASS Anxiety 
Score 
DASS Stress 
Score 
Mann-Whitney U  410.000  280.500  327.000 
Wilcoxon W  1685.000  1555.500  1602.000 
Z  -6.033  -6.896  -6.403 
Asymp. Sig. (2-tailed)  .000  .000  .000 
a. Grouping Variable: 1=Good Sleeper; 2=Insomnia; 3=NREM Parasomnia 
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Ranks 
  1=Good Sleeper; 
2=Insomnia; 3=NREM 
Parasomnia  N  Mean Rank  Sum of Ranks 
DASS Depression Score  Good Sleeper  50  35.45  1772.50 
NREM Parasomnia  48  64.14  3078.50 
Total  98     
DASS Anxiety Score  Good Sleeper  50  32.96  1648.00 
NREM Parasomnia  48  66.73  3203.00 
Total  98     
DASS Stress Score  Good Sleeper  50  35.15  1757.50 
NREM Parasomnia  48  64.45  3093.50 
Total  98     
 
 
Test Statistics
a 
 
DASS 
Depression 
Score 
DASS Anxiety 
Score 
DASS Stress 
Score 
Mann-Whitney U  497.500  373.000  482.500 
Wilcoxon W  1772.500  1648.000  1757.500 
Z  -5.241  -6.116  -5.144 
Asymp. Sig. (2-tailed)  .000  .000  .000 
a. Grouping Variable: 1=Good Sleeper; 2=Insomnia; 3=NREM Parasomnia 
 
Ranks 
  1=Good Sleeper; 
2=Insomnia; 3=NREM 
Parasomnia  N  Mean Rank  Sum of Ranks 
DASS Depression Score  Insomnia  50  52.62  2631.00 
NREM Parasomnia  48  46.25  2220.00 
Total  98     
DASS Anxiety Score  Insomnia  50  49.06  2453.00 
NREM Parasomnia  48  49.96  2398.00 
Total  98     
DASS Stress Score  Insomnia  50  55.37  2768.50 
NREM Parasomnia  48  43.39  2082.50 
Total  98     
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Test Statistics
a 
 
DASS 
Depression 
Score 
DASS Anxiety 
Score 
DASS Stress 
Score 
Mann-Whitney U  1044.000  1178.000  906.500 
Wilcoxon W  2220.000  2453.000  2082.500 
Z  -1.117  -.158  -2.095 
Asymp. Sig. (2-tailed)  .264  .874  .036 
a. Grouping Variable: 1=Good Sleeper; 2=Insomnia; 3=NREM Parasomnia 
 
 
 
Multiple Comparisons 
Bonferroni 
Dependent Variable 
(I) 1=Good Sleeper; 
2=Insomnia; 3=NREM 
Parasomnia 
(J) 1=Good 
Sleeper; 
2=Insomnia; 
3=NREM 
Parasomnia 
Mean 
Difference 
(I-J) 
Std. 
Error  Sig. 
98.75% 
Confidence 
Interval 
Lower 
Bound 
Upper 
Bound 
PSWQtransformedlog  Good Sleeper  Insomnia  -.24788
*  .0570
5 
.000  -.4140  -.0818 
NREM 
Parasomnia 
-.24070
*  .0576
4 
.000  -.4085  -.0729 
Insomnia  Good 
Sleeper 
.24788
*  .0570
5 
.000  .0818  .4140 
NREM 
Parasomnia 
.00718  .0576
4 
1.000  -.1606  .1750 
NREM Parasomnia  Good 
Sleeper 
.24070
*  .0576
4 
.000  .0729  .4085 
Insomnia  -.00718  .0576
4 
1.000  -.1750  .1606 
Arousal Predisposition 
Score  
Good Sleeper  Insomnia  -3.760  1.503  .040  -8.14  .62 
NREM 
Parasomnia 
-5.590
*  1.519  .001  -10.01  -1.17 
Insomnia  Good 
Sleeper 
3.760  1.503  .040  -.62  8.14 
NREM 
Parasomnia 
-1.830  1.519  .691  -6.25  2.59 
NREM Parasomnia  Good 
Sleeper 
5.590
*  1.519  .001  1.17  10.01 
Insomnia  1.830  1.519  .691  -2.59  6.25 
Rehearsal   Good Sleeper  Insomnia  -1.440  .620  .065  -3.25  .37 
NREM 
Parasomnia 
-2.809
*  .627  .000  -4.63  -.98 
Outcome variables: parametric data   127 
Insomnia  Good 
Sleeper 
1.440  .620  .065  -.37  3.25 
NREM 
Parasomnia 
-1.369  .627  .092  -3.19  .46 
NREM Parasomnia  Good 
Sleeper 
2.809
*  .627  .000  .98  4.63 
Insomnia  1.369  .627  .092  -.46  3.19 
Emotional Inhibition   Good Sleeper  Insomnia  -1.100
*  .362  .009  -2.16  -.04 
NREM 
Parasomnia 
-1.317
*  .366  .001  -2.38  -.25 
Insomnia  Good 
Sleeper 
1.100
*  .362  .009  .04  2.16 
NREM 
Parasomnia 
-.217  .366  1.000  -1.28  .85 
NREM Parasomnia  Good 
Sleeper 
1.317
*  .366  .001  .25  2.38 
Insomnia  .217  .366  1.000  -.85  1.28 
 
 
Outcome variables: non-parametric post hoc pairwise comparisons (Mann-Whitney) 
 
Ranks 
  1=Good Sleeper; 
2=Insomnia; 3=NREM 
Parasomnia  N  Mean Rank  Sum of Ranks 
AAQII score   Good Sleeper  50  38.94  1947.00 
Insomnia  50  62.06  3103.00 
Total  100     
 
Test Statistics
a 
  AAQII score  
Mann-Whitney U  672.000 
Wilcoxon W  1947.000 
Z  -3.994 
Asymp. Sig. (2-tailed)  .000 
a. Grouping Variable: 1=Good Sleeper; 
2=Insomnia; 3=NREM Parasomnia 
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Ranks 
  1=Good Sleeper; 
2=Insomnia; 3=NREM 
Parasomnia  N  Mean Rank  Sum of Ranks 
AAQII score   Good Sleeper  50  38.55  1927.50 
NREM Parasomnia  48  60.91  2923.50 
Total  98     
 
Test Statistics
a 
  AAQII score  
Mann-Whitney U  652.500 
Wilcoxon W  1927.500 
Z  -3.901 
Asymp. Sig. (2-tailed)  .000 
a. Grouping Variable: 1=Good Sleeper; 
2=Insomnia; 3=NREM Parasomnia 
 
Ranks 
  1=Good Sleeper; 
2=Insomnia; 3=NREM 
Parasomnia  N  Mean Rank  Sum of Ranks 
AAQII score   Insomnia  50  49.73  2486.50 
NREM Parasomnia  48  49.26  2364.50 
Total  98     
 
 
Test Statistics
a 
  AAQII score  
Mann-Whitney U  1188.500 
Wilcoxon W  2364.500 
Z  -.082 
Asymp. Sig. (2-tailed)  .935 
a. Grouping Variable: 1=Good Sleeper; 
2=Insomnia; 3=NREM Parasomnia 
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Ranks 
  1=Good Sleeper; 
2=Insomnia; 3=NREM 
Parasomnia  N  Mean Rank  Sum of Ranks 
Sleep Arousal Scale 
cognitive  
Good Sleeper  50  28.49  1424.50 
Insomnia  50  72.51  3625.50 
Total  100     
Sleep Arousal Scale 
somatic  
Good Sleeper  50  29.22  1461.00 
Insomnia  50  71.78  3589.00 
Total  100     
 
Test Statistics
a 
 
Sleep Arousal 
Scale cognitive  
Sleep Arousal 
Scale somatic  
Mann-Whitney U  149.500  186.000 
Wilcoxon W  1424.500  1461.000 
Z  -7.597  -7.520 
Asymp. Sig. (2-tailed)  .000  .000 
a. Grouping Variable: 1=Good Sleeper; 2=Insomnia; 
3=NREM Parasomnia 
 
Ranks 
  1=Good Sleeper; 
2=Insomnia; 3=NREM 
Parasomnia  N  Mean Rank  Sum of Ranks 
Sleep Arousal Scale 
cognitive  
Good Sleeper  50  35.44  1772.00 
NREM Parasomnia  48  64.15  3079.00 
Total  98     
Sleep Arousal Scale 
somatic  
Good Sleeper  50  33.80  1690.00 
NREM Parasomnia  48  65.85  3161.00 
Total  98     
 
 
Test Statistics
a 
 
Sleep Arousal 
Scale cognitive  
Sleep Arousal 
Scale somatic  
Mann-Whitney U  497.000  415.000 
Wilcoxon W  1772.000  1690.000 
Z  -5.008  -5.818 
Asymp. Sig. (2-tailed)  .000  .000 
a. Grouping Variable: 1=Good Sleeper; 2=Insomnia; 
3=NREM Parasomnia 
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Ranks 
  1=Good Sleeper; 
2=Insomnia; 3=NREM 
Parasomnia  N  Mean Rank  Sum of Ranks 
Sleep Arousal Scale 
cognitive  
Insomnia  50  63.17  3158.50 
NREM Parasomnia  48  35.26  1692.50 
Total  98     
Sleep Arousal Scale 
somatic  
Insomnia  50  53.88  2694.00 
NREM Parasomnia  48  44.94  2157.00 
Total  98     
 
Test Statistics
a 
 
Sleep Arousal 
Scale cognitive  
Sleep Arousal 
Scale somatic  
Mann-Whitney U  516.500  981.000 
Wilcoxon W  1692.500  2157.000 
Z  -4.864  -1.565 
Asymp. Sig. (2-tailed)  .000  .118 
a. Grouping Variable: 1=Good Sleeper; 2=Insomnia; 
3=NREM Parasomnia 
 
 
ECQ-EI, ECQ-R, PSWQ and APS between group ANCOVA using age as a 
covariate  
 
Tests of Between-Subjects Effects 
Dependent Variable:Emotional Inhibition (ECQ-EI) 
Source  Type III Sum of 
Squares  Df  Mean Square  F  Sig. 
Corrected Model  50.353
a  3  16.784  5.087  .002 
Intercept  370.784  1  370.784  112.376  .000 
Age  1.040  1  1.040  .315  .575 
 Group   48.733  2  24.366  7.385  .001 
Error  475.127  144  3.299     
Total  4839.000  148       
Corrected Total  525.480  147       
a. R Squared = .096 (Adjusted R Squared = .077) 
 
Dependent Variable:Emotional Inhibition (ECQ-EI) 
Group 
Mean  Std. Error 
95% Confidence Interval 
Lower Bound  Upper Bound 
dimension
1 
Good Sleeper  4.616
a  .258  4.105  5.127 
   Insomnia  5.642
a  .277  5.095  6.189 
NREM Parasomnia  5.960
a  .273  5.420  6.501 
a.  Covariates  appearing  in  the  model  are  evaluated  at  the  following  values:  Age 
(years) = 38.91. 
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Tests of Between-Subjects Effects 
Dependent Variable:Rumination (ECQ_R) 
Source  Type III Sum of 
Squares  Df  Mean Square  F  Sig. 
Corrected Model  193.919
a  3  64.640  6.677  .000 
Intercept  447.313  1  447.313  46.202  .000 
Age  .523  1  .523  .054  .816 
Group   193.169  2  96.585  9.976  .000 
Error  1394.156  144  9.682     
Total  6597.000  148       
Corrected Total  1588.074  147       
a. R Squared = .122 (Adjusted R Squared = .104) 
 
Dependent Variable:Rumination (ECQ-R)  
Group 
Mean  Std. Error 
95% Confidence Interval 
Lower Bound  Upper Bound 
dimension
1 
Good Sleeper  4.431
a  .443  3.556  5.306 
Insomnia  5.819
a  .474  4.882  6.756 
NREM Parasomnia  7.260
a  .468  6.334  8.186 
a.  Covariates  appearing  in  the  model  are  evaluated  at  the  following  values:  Age 
(years) = 38.91. 
 
 
Tests of Between-Subjects Effects 
Dependent Variable: Worry (PSWQ datatransformed)  
Source  Type III Sum of 
Squares  Df  Mean Square  F  Sig. 
Corrected Model  1.978
a  3  .659  8.050  .000 
Intercept  196.291  1  196.291  2396.132  .000 
Age  .000  1  .000  .001  .970 
Group  1.941  2  .970  11.845  .000 
Error  11.796  144  .082     
Total  2090.641  148       
Corrected Total  13.775  147       
a. R Squared = .144 (Adjusted R Squared = .126) 
 
 
 
Dependent Variable:PSWQtransformedlog 
Group 
Mean  Std. Error 
95% Confidence Interval 
Lower Bound  Upper Bound 
dimension
1 
Good Sleeper  3.584
a  .041  3.504  3.665 
Insomnia  3.832
a  .044  3.745  3.918 
NREM Parasomnia  3.825
a  .043  3.740  3.911 
a.  Covariates  appearing  in  the  model  are  evaluated  at  the  following  values:  Age 
(years) = 38.91. 
 
Tests of Between-Subjects Effects 
Dependent Variable:Arousal Predisposition Score  
Source  Type III Sum of 
Squares  Df  Mean Square  F  Sig. 
Corrected Model  981.731
a  3  327.244  5.884  .001 
Intercept  17353.360  1  17353.360  312.028  .000 
Age  181.888  1  181.888  3.271  .073 
Group  818.895  2  409.447  7.362  .001 
Error  8008.512  144  55.615     
Total  158120.000  148       
Corrected Total  8990.243  147       
a. R Squared = .109 (Adjusted R Squared = .091) 
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Dependent Variable:Arousal Predisposition Score  
Group 
Mean  Std. Error 
95% Confidence Interval 
Lower Bound  Upper Bound 
dimension
1 
Good Sleeper  28.450
a  1.061  26.353  30.548 
Insomnia  33.184
a  1.136  30.938  35.429 
NREM Parasomnia  33.673
a  1.123  31.453  35.892 
a.  Covariates  appearing  in  the  model  are  evaluated  at  the  following  values:  Age 
(years) = 38.91. 
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APPENDIX 2.10 
  Ethics approval letter 
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APPENDIX 2.11 
Participants removed from Good Sleeper group due to unequal sample sizes  
Participant   Gender   Age  
1*  Male   64 
2*  Female   26 
3*  Male   42 
4  Female   36 
5*  Male   27 
6  Male   41 
7*  Female   40 
8*  Female   43 
9*  Male   23 
10*  Female   32 
11  Male   25 
12  Female   38 
*= PSQI>5 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   138 
APPENDIX 2.12 
Socioeconomic status data for participants living in Scotland 
 
Socioeconomic 
status 
GS (N=50)  nREMp (N=30)  Insomnia 
(N=41) 
X
2 (2)  P 
   N(%)  N(%)  N(%)  N(%) 
SIMD quintile
a           
1  8  7  7  4.85  0.09 
2  3  5  12     
3  8  7  3     
4  12  6  6     
5  19  5  13     
                 
             
aSMID quintile = Scottish Index of Multiple Deprivaton.  A quintile represents a 
statistical value of a data set that represents 20% of a given population.  The first 
quartile represents the lowest fifth of the data (1-20%) (i.e. most deprived); the second 
quartile represents the second fifth (21%-40%) etc.   
 
(www.scotland.gov.uk/Topics/Statistics/SIMD) 
   
GS = Good Sleepers, nREMp = nREM parasomnia 
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APPENDIX 2.13 
Frequency of participants within each DASS severity category 
 
       
DASS severity categories  GS  nREMp  Insomnia 
(score  range  within 
category) 
N = 50  N=  50  N=  48 
   Frequency 
in category 
Frequency 
in category 
Frequency 
in category 
Depression        
Normal  (0-9)  49  35  31 
Mild (10-13)  1  3  4 
Moderate (14-20)  0  3  10 
Severe (21-27)  0  4  2 
Extremely severe (28+)  0  3  3 
        
Anxiety       
Normal (0-7)  50  24  31 
Mild (8-9)  0  9  8 
Moderate (10-14)  0  11  8 
Severe (15-19)  0  1  1 
Extremely Severe (20+)  0  3  2 
       
Stress        
Normal (0-14)  46  35  26 
Mild (15-18)  2  4  11 
Moderate (19-25)  2  4  6 
Severe (26-33)  0  3  7 
Extremely Severe (34+)  0  2  0 
       
GS = Good Sleepers, nREMp = nREM parasomnia 
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APPENDIX 2.14 
 Effect sizes for pair-wise comparisons of outcome measures 
Outcome Measure   Pairwise 
comparisons 
Effect size (d/r)  P 
Emotional Inhibition       
ECQ-EI
a  GS vs nREMp  0.69  0.001 
  GS vs I  0.63  0.009 
  I vs nREMp  0.12  1 
       
AAQ-II
b  GS vs nREMp  0.39  0.000 
  GS vs  I  0.4  0.000 
  I vs nREMp  0.01  0.935 
       
Rumination & Worry       
ECQ-R
a  GS vs nREMp  0.97  0.000 
  GS vs I  0.47  0.065 
  I vs nREMp  0.42  0.092 
       
PSWQ
a  GS vs nREMp  0.92  0.000 
  GS vs I  0.89  0.000 
  I vs nREMp  0.07  1 
       
Arousability       
APS
a  GS vs nREMp  0.79  0.001 
  GS vs I  0.5  0.040 
  I vs nREMp  0.23  0.691 
       
SAS cognitive
b  GS vs nREMp  0.51  0.000 
  GS vs I  0.76  0.000 
  I vs nREMp  0.49  0.000 
       
SAS somatic
b  GS vs nREMp  0.76  0.000 
  GS vs  I  0.58  0.000 
   I vs nREMp  0.16  0.118 
 
aEffect size = Cohen‟s d  
b Effect size =  r   
 
GS = Good Sleepers, nREMp = nREM parasomnia, I = Insomnia   141 
APPENDIX 2.15 
Correlation matrix between the five outcome measures and DASS subscales 
 
 
  
ECQ-EI   AAQ-II    ECQ-R  PSWQ  APS 
SAS 
cognitive  
SAS 
somatic  
DASS 
Depression 
DASS 
Anxiety  
DASS 
Stress  
ECQ-EI                                
AAQ-II  .303*                            
ECQ-R   .486*  .346*                         
PSWQ  .423*  .475*  .671*                      
APS    .413*  .530*  .607*  .668*                   
SAS cognitive    .324*  .395*  .376*  .487*  .407*                
SAS somatic   .295*  .493*  .310*  .435*  .496*  .601*             
DASS Depression   .366*  .587*  .308*  .443*  .462*  .462*  .555*          
DASS Anxiety   .457*  .511*  .337*  .484*  .544*  .523*  .694*  .582*       
DASS Stress  .414*  .522*  .482*  .613*  .540*  .614*  .579*  .660*  .669*    
 
*Correlation is significant at the 0.01 level (two-tailed)  142 
APPENDIX 2.16  
 
General Structure of Parasomnia Treatment Programme 
 
Background 
 
Relatively little is known about the psychological profile of people with Non-REM 
Parasomnias, but it seems reasonable on the basis of what is known to presume that 
sleepwalking  and  night  terrors  are  psychophysiological  disorders.    Therefore  they 
may  be  amenable  to  psychological  interventions.    We  are  currently  undertaking 
research  at  the  University  of  Glasgow  Sleep  Centre  exploring  the  psychological 
aspects of vulnerability and presentation of these patients.  We also have a regular 
clinic  for  people  with  Non-REM  Parasomnias.    The  Parasomnia  Treatment 
Programme  here,  therefore,  is  based  in  good  measure  upon  clinical  intuition  and 
experience.  Informal evaluation of this treatment programme by looking at outcomes 
and subjective value to patients will also give us a better understanding of the nature 
of Non-REM Parasomnias.   
 
The programme is structured as a 5 x 50 minute group session programme, in a style 
and format similar to the well established Glasgow CBT Programme for Insomnia.  
However the techniques are not by any means exclusively in the CBT tradition, but 
they are all influenced by psychological models of human behaviour, cognition and 
emotion. 
 
Session 1: Sleep Information and Education 
 
  Introduction to group and group members 
  What is sleep? 
  Sleep and human development 
  Common sleep disorders 
  Diagnostic features of Non-REM Parasomnia 
  How Non-REM Parasomnia differs from other forms of parasomnia 
  Relaxation training 
  Group discussion 
  Explanation of expectations of attending the group and of “boundaries” 
  Recognition  that  parasomnia  is  a  common  and  shared  problem  whilst  the 
opportunity for group discussion (within above boundaries) 
  Questions and answers (at the end, but also throughout) 
 
Session 2: Sleep-Wake Optimisation Therapy and Management of Risks 
 
  Establishing how much sleep you need 
  Sleeping at the right times 
  Managing napping and sleepiness 
  The use of ambient light and light-boxes 
  Avoiding sleep deprivation 
  Place of alcohol (and medications) 
  Creating a safe environment 
  Involving others to minimise risk   143 
  Group discussion  
  Questions and answers  
 
Session 3: Personal Styles and Ways of Coping 
 
  Analysis  of  questionnaire  data  (worry,  rumination,  emotional  expression, 
inhibition, etc.) 
  A mindful approach to who you are 
  Expressive writing tasks 
  Reflection, rehearsal and planning 
  Making sense of the parasomnia – a personal story 
  Group discussion  
  Questions and answers  
 
Session 4: De-conditioning and Behavioural Management 
 
  Predisposing, precipitating and perpetuating factors 
  Identifying internal and external triggers 
  Identifying stereo-type behaviour patterns 
  Introducing  discriminative  stimuli  to  aid  self-awareness  and/or  to  direct 
behaviour 
  Practicing extinction/de-conditioning 
  Involving a partner/carer in the treatment programme 
  Group discussion  
  Questions and answers  
 
Session 5: Additional Cognitive Strategies 
 
  Cognitive restructuring 
  Imagery training 
  Acceptance and commitment 
  Integration of the whole programme 
  Relapse prevention 
  Group discussion  
  Questions and answers  
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APPENDIX 2.17 
 
Major Research Project proposal 
 
Rumination,  worry,  emotional  inhibition  &  arousability  in  adults  with  NREM 
parasomnias, insomnia & good sleepers 
 
Abstract  
   
Background  
Little is  known about  the psychological  profiles  of adults  presenting  with  NREM 
parasomnias.  Research indicates that a common factor associated with the onset of 
NREM parasomnias is stress and there has been some investigation into the presence 
of mood disorders such as anxiety in people with NREM parasomnias, indicating a 
higher prevalence compared to healthy subjects.  There have been some suggestions 
that adults experiencing NREM parasomnias may be emotionally inhibited, however 
no  research  has  directly  investigated  this.    When  considering  research  into  sleep 
disorders, one turns to the topic of insomnia and finds a greater understanding of its 
associated psychological factors.  Several studies have found a relationship between 
both worry and rumination and sleep quality.  Research has also emphasised the role 
of somatic and especially cognitive arousal in insomnia.   
 
Aims 
The study proposed is an investigation into these psychological factors in adults who 
experience NREM parasomnias.   
 
Methods  
A cross-sectional study with a primary index NREM parasomnia group, a parallel 
sleep disorder group of adults with insomnia and a control group of good sleepers.  
The  three  groups  will  be  compared  for  differences  on  self-report  measures  of 
emotional inhibition, worry, rumination and arousal.      
 
Applications  
Gaining  a  deeper  understanding  of  some  of  the  psychological  processes  in  adults 
experiencing NREM parasomnias could prove useful for clinicians when providing 
assessment and intervention with people presenting with these phenomena.   
 
Introduction 
What are NREM parasomnias?  
The group of sleep disorders collectively known as parasomnias are characterised as 
“undesirable physical or behavioural phenomena occurring during the sleep period” 
(Wills & Garcia 2002).  Common parasomnias include REM (Rapid Eye Movement) 
sleep behaviour disorder, nocturnal seizures, rhythmic movement disorders, bruxism 
and Non REM (NREM) sleep-arousal disorder (Wills et al 2002).  The study proposal 
described  below  will  focus  on  NREM  sleep-arousal  disorders,  also  referred  to  as 
“NREM parasomnias”.  Overall characteristics of NREM parasomnias are that they 
tend to arise from stages 3 and 4 of NREM sleep (slow wave sleep) and in the first   145 
third  of  the  sleep  cycle  (Mahawold  &  Bourneman  2005).    The  episode  generally 
occurs in the first half of the night and the individual has near-total or total amnesia 
following the event (Vaughn & O‟Neil 2007).  This category of parasomnias includes 
night  terrors,  sleepwalking  and  confusional  arousals  (Mahawold  et  al  2005).  
Confusional arousals present as periods of mental confusion occurring upon arousal 
or awakening from sleep (Ohayon, Guilleminault & Priest 1999).  Night or “sleep” 
terrors are episodes of extreme terror associated with intense vocalisation and body 
motility and high levels of autonomic discharge (Kales, Cadieux, Soldatos & Kales 
1982).  The individual is completely fixated on this frightening experience and, whilst 
awareness is restricted as such, can not be reassured (Crisp 1996).  Sleepwalking or 
“somnambulism”  is  characterised  by  ambulatory  activity  during  NREM  sleep.  
Sleepwalking and night terrors have been reported in some cases to occur together 
(Ohayon et al 1999). 
 
These  NREM  parasomnias  are  described  in  the  International  Classification  of 
Diseases  (ICD-10)  (World  Health  Organisation  1992)  and  the  International 
Classification of Sleep Disorders (ICSD2) (American Academy of Sleep Medicine, 
2005).  In addition to the three main types described, more specific forms of NREM 
parasomnias have been reported including sleep-related eating disorder and sleep sex 
(Mahawold et al 2005).      
 
Prevalence of NREM parasomnias 
Incidents of confusional arousals, night terrors and sleepwalking are all more common 
in  children  than  adults  and  usually  decrease  in  frequency  with  increasing  age 
(Mahawold et al 2005).  However their prevalence in adults has been found to be 
higher than is often assumed (Bornemann, Mahowald & Schenck, 2006).  In a study 
based on self-report data in a sample from the UK general population, Ohayon and 
colleagues  found  that  night  terrors  were  reported  by  2.2%  of  the  participants, 
sleepwalking by 2% and confusional arousals by 4.2% (Ohayon et al 1999).  In the 
same study no gender differences were found in any of the arousal disorders, however 
some studies have reported that sleepwalking is around twice as common in males 
compared to females (Crisp 1996). 
 
Why study NREM parasomnias?  
Most often people who experience NREM parasomnias live out their lives without 
coming to the attention of researchers or sleep professionals.  Professionals are only 
likely  to  become  involved  when  harm  is  caused  to  the  individual,  the  disorder 
becomes an inconvenience to others (such as the bed partner), it causes interruptions 
to sleep, or when secondary complications such as alcohol dependence arise (Crisp 
1996).  In severe cases incidents of homicide, filicide and suicide have been reported 
(Bornemann et al 2006).   Increasingly, experts in the field of these disorders are 
asked to give their opinion in legal cases where violent or injurious behaviours have 
purported to have arisen from sleep (Mahowold & Schenk 2005).   
Given  the  potential  harmful,  in  some  cases  lethal,  consequences  of  NREM 
parasomnias and the possible impact on an individual‟s quality of life, it is important 
to find out about the characteristics of those who experience them.  In particular it is 
important to delineate those factors that predispose, precipitate and perpetuate these   146 
behaviours  with  the  ultimate  aim  being  to  intervene  where  possible  to  reduce  or 
eliminate their occurrence.  
 
What do we know about NREM parsomnias and when they occur?  
A common factor found to be associated with the onset of NREM parasomnias is 
stress  (Pressman 2007).   In the study described above by Ohayon and colleagues 
higher rates of stressful life events and mental stress in the past year were reported in 
the group who experienced NREM parasomnias compared with those experiencing no 
such behaviour (Ohayon et al 1999).  Sleep deprivation and alcohol consumption have 
also  been  reported  to  be  associated  with  NREM  parasomnias  (Pressman  2007).  
Investigating what factors were associated with the three main NREM parasomnias 
separately  and controlling for possible effects  of sleep deprivation,  life stress  and 
mental  and  sleep  disorders,  Ohayan  found  that  factors  associated  with  NREM 
parasomnias were shift work, daytime sleepiness and daily smoking.  A subjective 
sense of choking or blocked breathing at night, alcohol consumption at bedtime and 
nightmares  at  least  one  night  per  month  were  associated  with  night  terrors.  
Sleepwalking  was  also  associated  with  a  subjective  sense  of  choking  or  blocked 
breathing at night as well as being involved in a road accident in the past year.              
There  has  been  some  investigation  into  a  possible  relationship  between 
psychopathology and NREM parasomnias.  Interestingly Kales and colleagues found 
more intense clinical manifestations and high levels of psychopathology in adult-onset 
sleepwalkers compared with adults who had been sleepwalkers in childhood (Kales, 
Soldatos,  Caldwell,  Kales,  Humphrey  &  Charney  1980).    Ohayon  found  a  high 
percentage  of  subjects  with  NREM  parasomnias  had  concurrent  mood  or  anxiety 
disorders, specifically mood disorders were found in 30.4% of those with night terrors 
and 14.6% with sleepwalking compared with only 5.7% in healthy subjects (Ohayon 
et al 1999).  
In a study investigating personality and psychoneurotic characteristics of adults with 
either  sleepwalking  or  night  terrors,  Crisp  and  his  colleagues  found  a  normal 
psychological profile apart from exceptionally high scores on hysteria in both groups 
and  high  anxiety  scores  in  the  night  terrors  group  (Crisp,  Matthews,  Oakey  & 
Crutchfield, 1990).  Crisp notes that questions within the hysteria scale most often 
responded to positively were those to do with enjoying acting, dramatic situations, 
being  the  centre  of  attention  and  in  the  case  of  night  terrors,  being  excessively 
emotional, but that few of these patients displayed such behaviour in wakefulness 
(Crisp 1996).  In reviewing literature on night terrors, Carlson et al (Carlson, White & 
Turkat, 1982) similarly points to a tendency of people with night terrors to “react with 
fear and apprehension and inhibit outward expression”.  Concurrent with this is the 
finding  that  sleepwalking  and  night  terrors  are  more  common  in  good,  compliant 
children who do not show their emotions (Klackenberg 1982).  Despite these findings 
there  has  been  no  research  directly  investigating  emotional  expression  or  coping 
styles in adults presenting with arousal disorders.  
 
Turning to Insomnia 
When considering research into sleep disorders, one can turn to the topic of insomnia 
and find a greater understanding of its associated factors.  Increasing age, female sex 
and psychiatric, in particular anxiety and depression, and medical disorders are all 
consistently found to be risk factors for insomnia (Edinger & Means, 2005).  As has   147 
been found with NREM parasomnias, various studies have shown that negative or 
stressful  life  events  are  often  associated  with  insomnia  (Morin,  Rodrigez  &  Ivers 
2003).  In light of this some studies have investigated the role of appraisal of stressful 
events and coping in mediating between stress and insomnia.  Morin and colleagues 
reported that the frequency of daily minor stresses was comparable for good and poor 
sleepers but the perceived impact of those stressors was higher for insomniacs.  It was 
suggested that it is the appraisal process rather than the stress itself that is implicated 
in  the  presentation  of  insomnia.  Vela-Bueno  found  that  poor  sleep  quality  was 
associated with rumination and emotional inhibition and that emotional inhibition acts 
as a mediating factor between rumination and sleep quality (Vela-Bueno, Fernandez-
Mendoza,  Vgontzas,  Ramos-Paton,  Bixler,  Olaverrieta-Bernardino  &  Dela  Cruz-
Troca, 2008).   In another study investigating links between rumination and sleep, 
Thomsen  and  colleagues  found  a  significant  association  between  rumination  and 
subjective sleep quality even after controlling for negative mood (Thomsen, Mehlsen, 
Christensen & Zachariae, 2003).  An experimental study inducing rumination about a 
negative event in the pre-sleep period established a causal link whereby high-trait 
ruminators  allocated  to  a  rumination  condition  reported  poorer  sleep  quality  than 
those  assigned  to  a  distraction  condition.    Low-trait  ruminators  did  not  differ 
according to condition (Guastella & Moulds 2003).  Research has also shown a link 
between  insomnia  and  the  concept  of  “worry”  which  tends  to  be  associated  with 
anxiety (Harvey & Greenall, 2003).  Further research highlights the role of cognitive 
hyperarousal or arousability as a causal factor for insomnia (Coren, 1988).  There 
have been a number of research studies demonstrating a link between physiological 
arousal and insomnia (Monroe, 1967, Bonnet & Arand, 1995).  However, Lichtsein 
and Rosenthal showed that insomniacs experienced their sleeping difficulties to be 
caused more by cognitive arousal than by somatic arousal (Lichtsein & Rosenthal, 
1980).    Nicasso  and  colleagues  later  developed  the  Pre-Sleep  Arousal  Scale 
encompassing  both  cognitive  and  somatic  manifestations  of  arousal  (Nicasso, 
Mendlowitz, Fussell  & Petras,  1985).  They found that whilst  both  cognitive and 
somatic  arousal  was  related  to  insomnia,  cognitive  arousal  showed  a  stronger 
relationship 
 
Aims and hypotheses 
 
Aims 
In light of what has been found out thus far with regards to people who experience 
NREM parasomnias, the proposed study aims to profile these phenomena in relation 
to  a  number  of  the  psychological  variables  introduced  above,  namely  emotional 
inhibition, worry, rumination and arousal.  A further objective would be to uncover 
any  specificity  of  these  variables  to  NREM  parasomnias  relative  to  another  sleep 
disorder.      A  cross-sectional  study  is  therefore  proposed  with  an  index  group  of 
interest being the NREM parasomnia group, a parallel sleep disorder group of people 
with insomnia and a control group of good sleepers. 
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 Hypotheses 
The study aims to test the following hypotheses:  
  It  is  first  hypothesised  that,  confirming  findings  from  previous  research, 
people with insomnia will have levels of a) Emotional inhibition, b)Worry,  
c)Rumination and d) Arousal that are elevated relative to good sleepers. 
  It  is  hypothesised  that,  relative  to  good  sleepers,  the  group  experiencing 
NREM parasomnia, also a psychophysiological disorder, will also have higher 
levels of: a) Emotional inhibition, b) Worry, c) Rumination and d) Arousal. 
Research questions 
It  is not  clear, however, whether there will be any differences on these variables 
between the NREM parasomnia and insomnia group and in what direction this may 
be.  There are therefore several research questions with regards to these two clinical 
groups:    
  Are there differences between the insomnia and NREM parasomnia group in 
the nature or degree of a) Emotional inhibition, b) Worry, c) Rumination and 
d) Arousal? 
 
Plan of Investigation 
Participants 
Participants allocated to the NREM parasomnia group and Insomnia will be selected 
based on criteria outlined in the (ICSD2) (American Academy of Sleep Medicine, 
2005) for NREM parasomnia and insomnia respectively.  Criteria for admission to the 
control group will include not meeting criteria for insomnia or NREM parasomnias 
and reporting satisfaction with the amount of sleep obtained, meeting research design 
criteria for good sleep.   
Inclusion Criteria  
  Participants to be included in the NREM parasomnia group must meet criteria 
for experiencing NREM parasomnias based on criteria outlined in the ICSD2  
  Participants  to  be  included  in  the  Insomnia  group  must  meet  criteria  for 
primary Insomnia based on criteria outlined in the ICSD2  
  Participants  to  be  included  in  the  control  group  will  include  not  meeting 
criteria for insomnia of NREM parasomnias and reporting satisfaction with the 
amount of sleep obtained.   
  For inclusion into each group, participants must be over 18 years of age and 
report English as their first language. 
Exclusion Criteria 
  Exclusion  criteria  for  all  groups  would  be  (a)  Symptomatic  evidence  of 
another sleep disorder (e.g. sleep apnoea or periodic limb movement disorder); 
(b)  Sleep  disturbance  attributed  to  a  psychiatric/medical  condition  or 
neurological disorder; (c) significant drug or alcohol use.  
   People meeting criteria for both a NREM parasomnia and insomnia will be 
excluded from the study.      149 
Recruitment Procedures 
Participants  will  be  recruited  from  the  general  population  through  the  media, 
advertisements  and  clinical  referrals  in  a  manner  consistent  with  the  UGSC 
experience and operational procedures.   Advertisements may be placed, for example, 
in  publications  e.g.  newspapers  or  the  UGSC  newsletter,  in  public  spaces  e.g.  in 
hospitals, and on the internet e.g. on the UGSC website.  Participants may also be 
identified via an existing database held at the UGSC which has details of participants 
who have not been suitable for previous research and have agreed to be contacted for 
future studies.  Additionally, some potential participants may be identified through the 
parasomnia clinic which is ongoing at the UGSC.  This study is planned to be part of 
a larger programme of research and recruitment may come directly as well as via a 
parallel study (Sarah Young).  Suitable participants recruited into the parallel study 
will be offered the opportunity to take part in this study and vice versa.   
It  is  expected  that  people  interested  in  participating  in  the  study  will  contact  the 
UGSC to declare an interest.  Potential participants would be screened via telephone 
using a standard screening interview administered to all participants intending to be 
involved in research at the UGSC in addition to screening interviews for insomnia and 
NREM parasomnias and specific health and demographic questions. This would be 
administered by staff members at the UGSC who are not involved in conducting the 
proposed study.  If deemed suitable, they will be sent an information sheet on this and 
the parallel study and a consent form through which participants can consent to this 
study and indicate if they would like to be contacted regarding the parallel study.  
Approximately one week after being sent this information, they will receive a phone 
call asking them if they wish to participate.    If they agree at this stage to participate 
in  the  study,  they  will  be  asked  if  they  would  like  to  participate  via  email, 
telephone/face-to-face interview or to receive the set of questionnaires by post. 
 
Design  
A between-groups cross-sectional study is proposed. 
 
Research Procedures 
It  is  expected  that  people  interested  in  participating  in  the  study  will  contact  the 
UGSC to declare an interest by telephone or by email.  Potential participants would be 
screened via telephone interview which will include the following:  
 
Standard  screening  interview  which  is  administered  to  all  potential  research 
participants  at  UGSC,  with  additional  questions  relating  to  health  and 
sociodemographic  factors  and  International  Classification  of  Sleep  Disorders  II 
(ISCD-II) diagnostic criteria for insomnia and NREM parasomnias. 
 
Pittsburg  Sleep  Quality  Index  (PSQI)(Buyesse,  Reynolds  III,  Monk,  Berman  & 
Kupter, 1989):  A self-report questionnaire which measures estimated sleep quality 
and disturbance over 1 month.  This will provide a quantitative measure of sleep 
disturbance as an addition to the above interview.  A global PSQI score of >5 has a 
reported sensitivity of 89.6% and specificity of 86.5% in distinguishing those with 
clinically significant sleep disturbance from those without.  The PSQI has been shown 
to have a satisfactory level of internal consistency (α = 0.83).  
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Depression Anxiety Stress Scales(21 items) (DASS21) (Henry & Crawford, 2004):  A 
21-item self-report measure of depression, anxiety and stress.  The DASS21 has been 
selected because it includes a specific stress scale and a large amount of data has been 
accumulated on this measure at the UGSC.  Internal consistency for the scales are 
satisfactory with α=0.93 for the total scale, and α=0.88 and α=0.82 and α=0.90 for the 
depression, anxiety and stress scales respectively.   
 
Sleep Conditioner Indicator (SCI) (Espie 2009): An unpublished measure which has 
been developed at the UGSC and for which data has thus far been collected on nearly 
2000 people.  The SCI is a self-report questionnaire in which participants are asked to 
report on the pattern of their sleep over the past month in addition to the quality of 
their sleep, the impact any poor sleep has had on their life and the level of concern 
they have had about their sleep.  Participants are also asked about the history of sleep 
problems.           
 
If deemed suitable according to the inclusion/exclusion criteria defined, they will be 
sent information sheets on this and a parallel study along with two separate consent 
forms. 
 
Approximately one week after being sent this information, they will receive a phone 
call asking them if they have considered participating in either of the research projects.      
 
If they agree at this stage to participate in this particular study, they will be asked if 
they would like to participate via email, telephone/face-to-face interview or to receive 
the  set  of  questionnaires  by  post.    Depending  on  the  preference  indicated,  an 
appointment  will  be  arranged  with  participants  for  a  telephone  or  face-to-face 
interview, they will be emailed a link to a website designed using survey monkey 
where they will be able to complete the questions online or they will be sent the 
questionnaires by post.  The questionnaires described below will be completed by 
each participant.  
 
Questions on Emotional Inhibition 
Emotion Inhibition Subscale of the Emotion Control Questionnaire (ECQ-R) (Roger 
& Najarian, 1989).  Participants are asked to rate 14 statements and situations as 
generally “true” or “false”.  E.g. “people find it difficult to tell if I‟m excited about 
something or not”.  The Emotion Inhibition Subscale has been shown to have good 
internal consistency (α=0.77) and test retest reliability (r=0.71) (Roger et al 1989).    
 
Acceptance  & Action Questionnaire  – II (AAQ-II) (Hayes et al 2009):  A 9-item 
questionnaire  that  measures  experiential  avoidance.    Questionnaire  has  good 
psychometric properties.* 
 
Questions on Rumination 
The Rehearsal Subscale of the ECQ-R.   Participants are asked to rate 14 statements 
and situations as generally “true” or “false”. Eg “I get worked up just thinking about 
things that have upset me in the past” “I remember things that upset me or make me 
angry for a long time afterward”.  The Rehearsal Subscale has been shown to have 
high internal consistency (α=0.86) and test  re-test reliability (r=0.80) (Roger et al 
1989).  
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Questions on Worry 
Penn  State  Worry  Questionnaire  (PSWQ)  (Meyer,  Miller,  Metzger  &  Borkovec, 
2004):  A 16 item self-report instrument which measures the trait of worry.  The 
PSWQ has strong internal consistency (α=0.95) and test re-test reliability (r=0.93). 
 
Questions on Arousability 
Arousal  Predisposition  Scale  (APS)  (Coren  &  Mah,1988):  A  12-item  self-report 
measure of arousability. The APS has a split-half reliability of 0.83 and has been 
shown to predict individual differences in physiological arousal (Coren et al 1988). 
 
The Sleep Arousal Scale (Nicasso, Mendlowitz, Fussell & Petras,1985):  A 16-item 
self-report measure which comprises both cognitive and somatic manifestations of 
arousal.  Internal consistency for somatic (8 items) and cognitive (8 items) are good 
(α=0.81 and α=0.76 respectively).      
 
It  is  anticipated  that  it  should  take  approximately  20  minutes  for  a  participant  to 
complete this set of questionnaires.  For participants who have opted for the face-to-
face or telephone interviews, these will take place at the UGSC between 9am and 4pm 
on working week days.  Participants completing the online and postal questionnaires 
will be asked to complete these by a specified date allowing time for data analysis and 
write-up.  All participants will be asked to return a signed consent form.  
 
Justification of sample size  
No previous studies investigating any of the variables of arousal, emotional inhibition, 
worry  and  rumination  in  relation  to  a  NREM  parasomnia  population  have  been 
identified on which to base an estimated effect size. However studies investigating 
insomnia groups compared to controls have yielded large effect sizes.  For example, 
using data from a study by Harvey & Greenall, 2003, an effect size of d=1.07 was 
found between an insomnia group compared to good sleepers on measures of worry, 
which would correspond to a large effect size according to Cohen‟s (1988) effect size 
conventions.      In  answering  its  final  research  question,  the  proposed  study  is 
investigating possible differences between two clinical populations and it is likely that 
sufficient power will be required to detect a more conservative, medium effect size.   
A  priori  sample  size  calculations  were  conducted  using  the  G*Power  3  software 
program (Faul, Erdfelder, Lang & Buchner, 2007) for an independent samples t-test 
(two-tailed).  With a significance level set at 0.05, a standard power of 0.8 and a 
medium effect size of d=0.5, it was calculated that a sample size of 64 would be 
required in each group.  I would aim to recruit up to 100 participants per group.  It is 
expected that obtaining this sample size would be sufficient to detect any significant 
differences between the two clinical groups, in addition to differences between the 
clinical and control groups.   
 
Settings and Equipment   
All research procedures will take place at the UGSC.  Equipment required will be a 
computer, printer, paper and envelopes (including freepost) and a telephone.   
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Data Analysis 
Data will first be summarised to provide descriptive statistics.  Before conducting 
formal analysis, all variables will be checked for normal distribution.  The intention 
would be to use a parametric approach and therefore use ANOVA models.  If the data 
are not normally distributed, the data will be transferred to normative data or non-
parametric tests would be used.  Group comparisons will be made using ANOVA to 
check  that  the  three  groups  do  not  differ  with  respect  to  age,  gender  and 
socioeconomic status.  To investigate group differences with regard to the dependent 
variables (Emotional inhibition, worry, rumination and arousal), a series of ANOVA 
will be used.  If significant differences are found, a Bonferroni correction for multiple 
comparisons will be applied and the ANOVAs will be repeated.  Any variance of age, 
gender  and  socioeconomic  status  will  be  taken  into  account  using  ANCOVA.  
Relationships between the variables will be explored using correlations.   
  
 
Health and Safety Issues  
 
Researcher Safety Issues  
No researcher safety issues have been identified  
 
Participant Safety Issues 
If concerns are identified regarding a participants physical or mental health at any 
stage of the study, this will be reviewed by a clinical psychologist and an appropriate 
health professional will be contacted with the participants consent. Participants will 
also be given the opportunity to receive advice regarding their insomnia or NREM 
parasomnia  
 
Ethical Issues (including where submissions will be made) 
 
NHS ethical approval and R&D approval will be sought from the Greater Glasgow & 
Clyde and Ayrshire & Arran Health Boards.  Once this is passed, the study protocol 
will be shared with the Woolcock Institute in Sydney.  Should the Woolcock Institute 
be interested in recruiting for the study, they would have responsibility for gaining 
ethical approval via local procedures.  This is likely to be through the Royal Prince 
Alfred  Hospital  in  Sydney.    Completion  of  the  proposed  study  is  dependent  on 
recruitment from Glasgow and the United Kingdom alone and any recruitment from 
the Woolcock Institute will be supplementary to this.  
 
   
Financial Issues  
Equipment costs, travel etc  
     Financial  aid  for  paper,  printing  and  photocopying.  Envelopes,  stamps/freepost 
envelopes  will  be  required  to  send  out  questionnaires  and  have  them  returned.  
Subscription to survey monkey.  A full costing summary will be submitted separately 
for approval.   
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Timetable  
 
Date  MRP Progress/Tasks 
  
April 2010 
  
MRP Proposal submitted 
Costing form submission 
Completion of health and safety form 
  
May – September 2010  MRP research supervision agreement 
Start research logbook 
Ethics approval 
Research & Development approval 
Site preparation 
Ordering materials and administration supplies 
  
October 2010  Research Progress Meeting 1 
  
October – December 2010  Start data collection 
  
January – March 2011  Complete data collection 
Research Progress Meeting 2 
  
April – May 2011  Complete data analyses 
Research Progress Meeting 3 
  
June – July 2011  Submit drafts to supervisor 
  
July 2011  Loose bind and submit 
  
August 2011  Viva preparation 
  
September 2011  Viva 
  
September – November 2011  Submit corrections (if required) 
  
 
Practical Applications  
 
It is hoped that the outcome of this study would inform the assessment and treatment 
of clinically presenting cases with NREM parasomnias. 
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*Minor change to major research project: Used revised 7-item version of Acceptance 
and Action Questionnaire – II (AAQ-II), with improved psychometric properties 
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